WO2010061186A2 - Plant plastid transformation method - Google Patents
Plant plastid transformation method Download PDFInfo
- Publication number
- WO2010061186A2 WO2010061186A2 PCT/GB2009/002754 GB2009002754W WO2010061186A2 WO 2010061186 A2 WO2010061186 A2 WO 2010061186A2 GB 2009002754 W GB2009002754 W GB 2009002754W WO 2010061186 A2 WO2010061186 A2 WO 2010061186A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- plant
- sequence
- nucleic acid
- plastid
- cell
- Prior art date
Links
- 210000002706 plastid Anatomy 0.000 title claims abstract description 158
- 238000011426 transformation method Methods 0.000 title description 6
- 210000004027 cell Anatomy 0.000 claims abstract description 151
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 124
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 98
- 238000000034 method Methods 0.000 claims abstract description 86
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 79
- 239000013598 vector Substances 0.000 claims abstract description 34
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 23
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 23
- 241000196324 Embryophyta Species 0.000 claims description 303
- 210000003763 chloroplast Anatomy 0.000 claims description 155
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 81
- 230000005945 translocation Effects 0.000 claims description 81
- 108700019146 Transgenes Proteins 0.000 claims description 76
- 230000009466 transformation Effects 0.000 claims description 70
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 64
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 55
- 230000014509 gene expression Effects 0.000 claims description 54
- 230000027455 binding Effects 0.000 claims description 51
- 241000208125 Nicotiana Species 0.000 claims description 49
- 102100034343 Integrase Human genes 0.000 claims description 35
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims description 34
- 108010031100 chloroplast transit peptides Proteins 0.000 claims description 32
- 102000040430 polynucleotide Human genes 0.000 claims description 27
- 108091033319 polynucleotide Proteins 0.000 claims description 27
- 239000002157 polynucleotide Substances 0.000 claims description 27
- 241000219194 Arabidopsis Species 0.000 claims description 26
- 108020004414 DNA Proteins 0.000 claims description 26
- 240000007594 Oryza sativa Species 0.000 claims description 25
- 235000007164 Oryza sativa Nutrition 0.000 claims description 25
- 235000009566 rice Nutrition 0.000 claims description 25
- 230000009261 transgenic effect Effects 0.000 claims description 21
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 19
- 239000012634 fragment Substances 0.000 claims description 18
- 240000008042 Zea mays Species 0.000 claims description 17
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 17
- 241000894007 species Species 0.000 claims description 16
- 241000589158 Agrobacterium Species 0.000 claims description 15
- 230000001086 cytosolic effect Effects 0.000 claims description 14
- 108700007698 Genetic Terminator Regions Proteins 0.000 claims description 12
- 238000004519 manufacturing process Methods 0.000 claims description 12
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 12
- 235000021307 Triticum Nutrition 0.000 claims description 11
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims description 10
- 235000009973 maize Nutrition 0.000 claims description 10
- 230000002441 reversible effect Effects 0.000 claims description 10
- 244000061176 Nicotiana tabacum Species 0.000 claims description 9
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 9
- 108091008324 binding proteins Proteins 0.000 claims description 9
- 229920001184 polypeptide Polymers 0.000 claims description 8
- 229920000742 Cotton Polymers 0.000 claims description 7
- 244000068988 Glycine max Species 0.000 claims description 7
- 235000010469 Glycine max Nutrition 0.000 claims description 7
- 108091029499 Group II intron Proteins 0.000 claims description 7
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 7
- 235000005822 corn Nutrition 0.000 claims description 7
- 230000001172 regenerating effect Effects 0.000 claims description 7
- 241001430294 unidentified retrovirus Species 0.000 claims description 7
- 102000003951 Erythropoietin Human genes 0.000 claims description 6
- 108090000394 Erythropoietin Proteins 0.000 claims description 6
- 240000005979 Hordeum vulgare Species 0.000 claims description 6
- 102000044126 RNA-Binding Proteins Human genes 0.000 claims description 6
- 241000726445 Viroids Species 0.000 claims description 6
- 230000001580 bacterial effect Effects 0.000 claims description 6
- 229940105423 erythropoietin Drugs 0.000 claims description 6
- 229940088597 hormone Drugs 0.000 claims description 6
- 239000005556 hormone Substances 0.000 claims description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 6
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 claims description 6
- 230000001131 transforming effect Effects 0.000 claims description 6
- 239000011782 vitamin Substances 0.000 claims description 6
- 229940088594 vitamin Drugs 0.000 claims description 6
- 229930003231 vitamin Natural products 0.000 claims description 6
- 235000013343 vitamin Nutrition 0.000 claims description 6
- 235000011331 Brassica Nutrition 0.000 claims description 5
- 241000219198 Brassica Species 0.000 claims description 5
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 claims description 5
- 235000006008 Brassica napus var napus Nutrition 0.000 claims description 5
- 240000000385 Brassica napus var. napus Species 0.000 claims description 5
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 claims description 5
- 235000004977 Brassica sinapistrum Nutrition 0.000 claims description 5
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 5
- 240000004713 Pisum sativum Species 0.000 claims description 5
- 235000010582 Pisum sativum Nutrition 0.000 claims description 5
- -1 haemoglobin Proteins 0.000 claims description 5
- 239000004009 herbicide Substances 0.000 claims description 5
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 239000005562 Glyphosate Substances 0.000 claims description 4
- 241000219146 Gossypium Species 0.000 claims description 4
- 244000061456 Solanum tuberosum Species 0.000 claims description 4
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 4
- 238000004113 cell culture Methods 0.000 claims description 4
- 239000002299 complementary DNA Substances 0.000 claims description 4
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 claims description 4
- 229940097068 glyphosate Drugs 0.000 claims description 4
- 230000002363 herbicidal effect Effects 0.000 claims description 4
- 239000000275 Adrenocorticotropic Hormone Substances 0.000 claims description 3
- 101000903721 Arabidopsis thaliana B-box zinc finger protein 24 Proteins 0.000 claims description 3
- 241000193388 Bacillus thuringiensis Species 0.000 claims description 3
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 claims description 3
- 241000220243 Brassica sp. Species 0.000 claims description 3
- 108060001064 Calcitonin Proteins 0.000 claims description 3
- 235000002566 Capsicum Nutrition 0.000 claims description 3
- 240000008574 Capsicum frutescens Species 0.000 claims description 3
- 102100023804 Coagulation factor VII Human genes 0.000 claims description 3
- 102000008186 Collagen Human genes 0.000 claims description 3
- 108010035532 Collagen Proteins 0.000 claims description 3
- 102400000739 Corticotropin Human genes 0.000 claims description 3
- 101800000414 Corticotropin Proteins 0.000 claims description 3
- 244000241257 Cucumis melo Species 0.000 claims description 3
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 claims description 3
- 235000002767 Daucus carota Nutrition 0.000 claims description 3
- 244000000626 Daucus carota Species 0.000 claims description 3
- 102400001368 Epidermal growth factor Human genes 0.000 claims description 3
- 101800003838 Epidermal growth factor Proteins 0.000 claims description 3
- 108010076282 Factor IX Proteins 0.000 claims description 3
- 108010023321 Factor VII Proteins 0.000 claims description 3
- 108010054218 Factor VIII Proteins 0.000 claims description 3
- 108010014173 Factor X Proteins 0.000 claims description 3
- 108010074864 Factor XI Proteins 0.000 claims description 3
- 108010080865 Factor XII Proteins 0.000 claims description 3
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 claims description 3
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 claims description 3
- 235000016623 Fragaria vesca Nutrition 0.000 claims description 3
- 240000009088 Fragaria x ananassa Species 0.000 claims description 3
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims description 3
- 102400000321 Glucagon Human genes 0.000 claims description 3
- 108060003199 Glucagon Proteins 0.000 claims description 3
- 102000004547 Glucosylceramidase Human genes 0.000 claims description 3
- 108010017544 Glucosylceramidase Proteins 0.000 claims description 3
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 claims description 3
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 claims description 3
- 108091027874 Group I catalytic intron Proteins 0.000 claims description 3
- 244000020551 Helianthus annuus Species 0.000 claims description 3
- 235000003222 Helianthus annuus Nutrition 0.000 claims description 3
- 241000238631 Hexapoda Species 0.000 claims description 3
- 108090001061 Insulin Proteins 0.000 claims description 3
- 102000004877 Insulin Human genes 0.000 claims description 3
- 102000006992 Interferon-alpha Human genes 0.000 claims description 3
- 108010047761 Interferon-alpha Proteins 0.000 claims description 3
- 102000003996 Interferon-beta Human genes 0.000 claims description 3
- 108090000467 Interferon-beta Proteins 0.000 claims description 3
- 102000008070 Interferon-gamma Human genes 0.000 claims description 3
- 108010074328 Interferon-gamma Proteins 0.000 claims description 3
- 102000014150 Interferons Human genes 0.000 claims description 3
- 108010050904 Interferons Proteins 0.000 claims description 3
- 235000003228 Lactuca sativa Nutrition 0.000 claims description 3
- 240000008415 Lactuca sativa Species 0.000 claims description 3
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 3
- 102400000050 Oxytocin Human genes 0.000 claims description 3
- XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 claims description 3
- 101800000989 Oxytocin Proteins 0.000 claims description 3
- 102000003982 Parathyroid hormone Human genes 0.000 claims description 3
- 108090000445 Parathyroid hormone Proteins 0.000 claims description 3
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 claims description 3
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 claims description 3
- 108010076181 Proinsulin Proteins 0.000 claims description 3
- 102000003946 Prolactin Human genes 0.000 claims description 3
- 108010057464 Prolactin Proteins 0.000 claims description 3
- 102000007562 Serum Albumin Human genes 0.000 claims description 3
- 108010071390 Serum Albumin Proteins 0.000 claims description 3
- 240000003768 Solanum lycopersicum Species 0.000 claims description 3
- 102000005157 Somatostatin Human genes 0.000 claims description 3
- 108010056088 Somatostatin Proteins 0.000 claims description 3
- 240000003829 Sorghum propinquum Species 0.000 claims description 3
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- 235000021536 Sugar beet Nutrition 0.000 claims description 3
- 102000011923 Thyrotropin Human genes 0.000 claims description 3
- 108010061174 Thyrotropin Proteins 0.000 claims description 3
- 101000983538 Triticum aestivum Casparian strip membrane protein 1 Proteins 0.000 claims description 3
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 3
- 240000006365 Vitis vinifera Species 0.000 claims description 3
- 229930013930 alkaloid Natural products 0.000 claims description 3
- 229940097012 bacillus thuringiensis Drugs 0.000 claims description 3
- 239000003114 blood coagulation factor Substances 0.000 claims description 3
- 229960004015 calcitonin Drugs 0.000 claims description 3
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 claims description 3
- 210000003855 cell nucleus Anatomy 0.000 claims description 3
- 229920001436 collagen Polymers 0.000 claims description 3
- 229960000258 corticotropin Drugs 0.000 claims description 3
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 claims description 3
- 229940126576 edible vaccine Drugs 0.000 claims description 3
- 229940116977 epidermal growth factor Drugs 0.000 claims description 3
- 229940012413 factor vii Drugs 0.000 claims description 3
- 230000035558 fertility Effects 0.000 claims description 3
- 229940028334 follicle stimulating hormone Drugs 0.000 claims description 3
- 229940044627 gamma-interferon Drugs 0.000 claims description 3
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 claims description 3
- 229960004666 glucagon Drugs 0.000 claims description 3
- 239000003102 growth factor Substances 0.000 claims description 3
- 239000003262 industrial enzyme Substances 0.000 claims description 3
- 229940125396 insulin Drugs 0.000 claims description 3
- 229940047124 interferons Drugs 0.000 claims description 3
- 230000001592 luteinising effect Effects 0.000 claims description 3
- 235000016709 nutrition Nutrition 0.000 claims description 3
- 229960001723 oxytocin Drugs 0.000 claims description 3
- XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 claims description 3
- 229960001319 parathyroid hormone Drugs 0.000 claims description 3
- 239000000199 parathyroid hormone Substances 0.000 claims description 3
- 235000013824 polyphenols Nutrition 0.000 claims description 3
- 108010066381 preproinsulin Proteins 0.000 claims description 3
- 229940097325 prolactin Drugs 0.000 claims description 3
- 229960000553 somatostatin Drugs 0.000 claims description 3
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 235000000346 sugar Nutrition 0.000 claims description 3
- 150000008163 sugars Chemical class 0.000 claims description 3
- 231100000331 toxic Toxicity 0.000 claims description 3
- 230000002588 toxic effect Effects 0.000 claims description 3
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 claims description 3
- 108090000565 Capsid Proteins Proteins 0.000 claims description 2
- 241000195493 Cryptophyta Species 0.000 claims description 2
- 102000002812 Heat-Shock Proteins Human genes 0.000 claims description 2
- 108010004889 Heat-Shock Proteins Proteins 0.000 claims description 2
- 206010021929 Infertility male Diseases 0.000 claims description 2
- 208000007466 Male Infertility Diseases 0.000 claims description 2
- 241000195887 Physcomitrella patens Species 0.000 claims description 2
- 108700020471 RNA-Binding Proteins Proteins 0.000 claims description 2
- 108020004511 Recombinant DNA Proteins 0.000 claims description 2
- 241000700605 Viruses Species 0.000 claims description 2
- 230000036579 abiotic stress Effects 0.000 claims description 2
- 230000004790 biotic stress Effects 0.000 claims description 2
- 230000000749 insecticidal effect Effects 0.000 claims description 2
- 230000001069 nematicidal effect Effects 0.000 claims description 2
- 238000003976 plant breeding Methods 0.000 claims description 2
- 235000013311 vegetables Nutrition 0.000 claims description 2
- 102000023732 binding proteins Human genes 0.000 claims 3
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims 2
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 claims 2
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 claims 2
- 240000003259 Brassica oleracea var. botrytis Species 0.000 claims 2
- 244000098338 Triticum aestivum Species 0.000 claims 2
- 240000007124 Brassica oleracea Species 0.000 claims 1
- 235000004221 Brassica oleracea var gemmifera Nutrition 0.000 claims 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 claims 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 claims 1
- 244000178937 Brassica oleracea var. capitata Species 0.000 claims 1
- 244000308368 Brassica oleracea var. gemmifera Species 0.000 claims 1
- 102400000113 Calcitonin Human genes 0.000 claims 1
- 241000219104 Cucurbitaceae Species 0.000 claims 1
- 241000207746 Nicotiana benthamiana Species 0.000 claims 1
- 244000128884 Zier Kohl Species 0.000 claims 1
- 239000001390 capsicum minimum Substances 0.000 claims 1
- 230000001177 retroviral effect Effects 0.000 claims 1
- 235000020354 squash Nutrition 0.000 claims 1
- 230000014616 translation Effects 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 61
- 238000010839 reverse transcription Methods 0.000 description 33
- 230000035897 transcription Effects 0.000 description 21
- 238000013518 transcription Methods 0.000 description 21
- 108020004566 Transfer RNA Proteins 0.000 description 19
- 108091092195 Intron Proteins 0.000 description 16
- 238000003780 insertion Methods 0.000 description 15
- 230000037431 insertion Effects 0.000 description 15
- 210000001519 tissue Anatomy 0.000 description 15
- 239000002773 nucleotide Substances 0.000 description 14
- 125000003729 nucleotide group Chemical group 0.000 description 14
- 101150067314 aadA gene Proteins 0.000 description 13
- 230000001939 inductive effect Effects 0.000 description 13
- 239000002609 medium Substances 0.000 description 12
- 210000000805 cytoplasm Anatomy 0.000 description 11
- 210000002257 embryonic structure Anatomy 0.000 description 11
- 238000005516 engineering process Methods 0.000 description 11
- 238000012546 transfer Methods 0.000 description 11
- 241000701489 Cauliflower mosaic virus Species 0.000 description 9
- 241000209140 Triticum Species 0.000 description 9
- 101150075980 psbA gene Proteins 0.000 description 9
- 230000001105 regulatory effect Effects 0.000 description 9
- 241000726301 Avocado sunblotch viroid Species 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 101150026213 atpB gene Proteins 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 210000004940 nucleus Anatomy 0.000 description 8
- 230000035755 proliferation Effects 0.000 description 8
- 108020004705 Codon Proteins 0.000 description 7
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 7
- 206010020649 Hyperkeratosis Diseases 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 239000003242 anti bacterial agent Substances 0.000 description 7
- 229940088710 antibiotic agent Drugs 0.000 description 7
- 238000013461 design Methods 0.000 description 7
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 7
- 229960000268 spectinomycin Drugs 0.000 description 7
- 102000014914 Carrier Proteins Human genes 0.000 description 6
- 108091026890 Coding region Proteins 0.000 description 6
- 101000625358 Homo sapiens Transcription initiation factor TFIID subunit 2 Proteins 0.000 description 6
- 241000723873 Tobacco mosaic virus Species 0.000 description 6
- 102100025041 Transcription initiation factor TFIID subunit 2 Human genes 0.000 description 6
- 238000002744 homologous recombination Methods 0.000 description 6
- 230000006801 homologous recombination Effects 0.000 description 6
- 210000001161 mammalian embryo Anatomy 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 210000003463 organelle Anatomy 0.000 description 6
- 229920002857 polybutadiene Polymers 0.000 description 6
- 230000002103 transcriptional effect Effects 0.000 description 6
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 5
- 108020005345 3' Untranslated Regions Proteins 0.000 description 5
- 230000006820 DNA synthesis Effects 0.000 description 5
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 5
- 241000709992 Potato virus X Species 0.000 description 5
- 239000005708 Sodium hypochlorite Substances 0.000 description 5
- 241001493065 dsRNA viruses Species 0.000 description 5
- 230000000408 embryogenic effect Effects 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000008929 regeneration Effects 0.000 description 5
- 238000011069 regeneration method Methods 0.000 description 5
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 5
- 229940027257 timentin Drugs 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 101710159080 Aconitate hydratase A Proteins 0.000 description 4
- 101710159078 Aconitate hydratase B Proteins 0.000 description 4
- 108090000144 Human Proteins Proteins 0.000 description 4
- 102000003839 Human Proteins Human genes 0.000 description 4
- 108010064851 Plant Proteins Proteins 0.000 description 4
- 101710105008 RNA-binding protein Proteins 0.000 description 4
- 244000057717 Streptococcus lactis Species 0.000 description 4
- 235000014897 Streptococcus lactis Nutrition 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 150000001413 amino acids Chemical group 0.000 description 4
- 101150088806 atpA gene Proteins 0.000 description 4
- 101150074451 clpP gene Proteins 0.000 description 4
- 238000009396 hybridization Methods 0.000 description 4
- 235000021118 plant-derived protein Nutrition 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 108700028369 Alleles Proteins 0.000 description 3
- 101710132601 Capsid protein Proteins 0.000 description 3
- 101710094648 Coat protein Proteins 0.000 description 3
- 108700010070 Codon Usage Proteins 0.000 description 3
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 3
- 101710203526 Integrase Proteins 0.000 description 3
- 101710125418 Major capsid protein Proteins 0.000 description 3
- 101710141454 Nucleoprotein Proteins 0.000 description 3
- 241000726318 Peach latent mosaic viroid Species 0.000 description 3
- 101710083689 Probable capsid protein Proteins 0.000 description 3
- 101150041925 RBCS gene Proteins 0.000 description 3
- 108020003564 Retroelements Proteins 0.000 description 3
- 108010003581 Ribulose-bisphosphate carboxylase Proteins 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 101150022916 TAF2 gene Proteins 0.000 description 3
- 108090000848 Ubiquitin Proteins 0.000 description 3
- 102400000757 Ubiquitin Human genes 0.000 description 3
- 101150007989 ags gene Proteins 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 101150038923 atpF gene Proteins 0.000 description 3
- 229960004261 cefotaxime Drugs 0.000 description 3
- AZZMGZXNTDTSME-JUZDKLSSSA-M cefotaxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 AZZMGZXNTDTSME-JUZDKLSSSA-M 0.000 description 3
- 230000033077 cellular process Effects 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 238000000126 in silico method Methods 0.000 description 3
- 230000000977 initiatory effect Effects 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229930182823 kanamycin A Natural products 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 230000008488 polyadenylation Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 description 3
- 229960001225 rifampicin Drugs 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 230000008685 targeting Effects 0.000 description 3
- 108020004465 16S ribosomal RNA Proteins 0.000 description 2
- 101150090724 3 gene Proteins 0.000 description 2
- 101100301006 Allochromatium vinosum (strain ATCC 17899 / DSM 180 / NBRC 103801 / NCIMB 10441 / D) cbbL2 gene Proteins 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 102000055006 Calcitonin Human genes 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 2
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 2
- 101150013191 E gene Proteins 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 229920002148 Gellan gum Polymers 0.000 description 2
- 101150023414 HSP60 gene Proteins 0.000 description 2
- 241000194036 Lactococcus Species 0.000 description 2
- 241000209510 Liliopsida Species 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 108060004795 Methyltransferase Proteins 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 241000726448 Satellite tobacco mosaic virus Species 0.000 description 2
- 108020004682 Single-Stranded DNA Proteins 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- 241000016010 Tomato spotted wilt orthotospovirus Species 0.000 description 2
- 108700009124 Transcription Initiation Site Proteins 0.000 description 2
- 108020000999 Viral RNA Proteins 0.000 description 2
- 101150008263 accD gene Proteins 0.000 description 2
- 101150035600 atpD gene Proteins 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 2
- 229960003669 carbenicillin Drugs 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 101150004101 cbbL gene Proteins 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 101150043719 clpP1 gene Proteins 0.000 description 2
- 101150102296 clpP2 gene Proteins 0.000 description 2
- 238000003501 co-culture Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 230000001338 necrotic effect Effects 0.000 description 2
- 108010058731 nopaline synthase Proteins 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 230000037039 plant physiology Effects 0.000 description 2
- 238000004161 plant tissue culture Methods 0.000 description 2
- 101150074945 rbcL gene Proteins 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 238000005215 recombination Methods 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 101150090202 rpoB gene Proteins 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 238000005204 segregation Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- CAAMSDWKXXPUJR-UHFFFAOYSA-N 3,5-dihydro-4H-imidazol-4-one Chemical class O=C1CNC=N1 CAAMSDWKXXPUJR-UHFFFAOYSA-N 0.000 description 1
- 101710197633 Actin-1 Proteins 0.000 description 1
- 102000004373 Actin-related protein 2 Human genes 0.000 description 1
- 108090000963 Actin-related protein 2 Proteins 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 101100378521 Arabidopsis thaliana ADH2 gene Proteins 0.000 description 1
- 101100524545 Arabidopsis thaliana RFS2 gene Proteins 0.000 description 1
- 101100045527 Arabidopsis thaliana TUBB7 gene Proteins 0.000 description 1
- 101100209903 Arabidopsis thaliana VLN1 gene Proteins 0.000 description 1
- 102100031491 Arylsulfatase B Human genes 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 241000209763 Avena sativa Species 0.000 description 1
- 235000007558 Avena sp Nutrition 0.000 description 1
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 description 1
- 101100205892 Caenorhabditis elegans taf-2 gene Proteins 0.000 description 1
- 101710163595 Chaperone protein DnaK Proteins 0.000 description 1
- 108010058432 Chaperonin 60 Proteins 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- 108020005133 Chloroplast RNA Proteins 0.000 description 1
- 239000005496 Chlorsulfuron Substances 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 102100031780 Endonuclease Human genes 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 101710178376 Heat shock 70 kDa protein Proteins 0.000 description 1
- 101710152018 Heat shock cognate 70 kDa protein Proteins 0.000 description 1
- 241001495448 Impatiens <genus> Species 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- 244000207740 Lemna minor Species 0.000 description 1
- 235000006439 Lemna minor Nutrition 0.000 description 1
- 101150005851 NOS gene Proteins 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 241000563929 Oreophasis derbianus Species 0.000 description 1
- 238000010222 PCR analysis Methods 0.000 description 1
- 108700001094 Plant Genes Proteins 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 235000001855 Portulaca oleracea Nutrition 0.000 description 1
- 241001515849 Satellite Viruses Species 0.000 description 1
- 244000249201 Scenedesmus obliquus Species 0.000 description 1
- 235000007122 Scenedesmus obliquus Nutrition 0.000 description 1
- 241000223892 Tetrahymena Species 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- JUGOREOARAHOCO-UHFFFAOYSA-M acetylcholine chloride Chemical compound [Cl-].CC(=O)OCC[N+](C)(C)C JUGOREOARAHOCO-UHFFFAOYSA-M 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 108010050625 agropine synthase Proteins 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 101150105110 atpF2 gene Proteins 0.000 description 1
- 101150018639 atpFH gene Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000005422 blasting Methods 0.000 description 1
- 108091092328 cellular RNA Proteins 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000011088 chloroplast localization Effects 0.000 description 1
- VJYIFXVZLXQVHO-UHFFFAOYSA-N chlorsulfuron Chemical compound COC1=NC(C)=NC(NC(=O)NS(=O)(=O)C=2C(=CC=CC=2)Cl)=N1 VJYIFXVZLXQVHO-UHFFFAOYSA-N 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 244000038559 crop plants Species 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000034373 developmental growth involved in morphogenesis Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 239000012869 germination medium Substances 0.000 description 1
- 101150118163 h gene Proteins 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Inorganic materials Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 1
- 229930190166 impatien Natural products 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 108010026228 mRNA guanylyltransferase Proteins 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000017066 negative regulation of growth Effects 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000003415 peat Substances 0.000 description 1
- 101150017854 petB gene Proteins 0.000 description 1
- 101150020513 petD gene Proteins 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000003007 single stranded DNA break Effects 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000005758 transcription activity Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8214—Plastid transformation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8217—Gene switch
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8221—Transit peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
- C12N15/8222—Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
- C12N15/8223—Vegetative tissue-specific promoters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/07—Nucleotidyltransferases (2.7.7)
- C12Y207/07049—RNA-directed DNA polymerase (2.7.7.49), i.e. telomerase or reverse-transcriptase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/85—Fusion polypeptide containing an RNA binding domain
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
Definitions
- the present invention relates to a method for producing heterologous or exogenous RNA species in plant cell material such as genetically transformed plant cells in culture, plant tissue and plants derived from genetically transformed plant cells.
- the method relates to a more efficient method for producing ⁇ RNA species and/or heterologous or exogenous proteins in plastids comprised in plant cell material, the genetic material required therefor, such as DNA and RNA, vectors, host cells, methods of introduction of genetic material into plant cells, plant cells comprising genetically modified plastids, and uses thereof .
- a disadvantage of prior art plant plastid transformation methods is that the transformation efficiency in terms of numbers of transformed plastids per cell tends to be low.
- a further disadvantage of prior art methods is that the delivery of genetic information into the plastid tends to be erratic in the sense that the delivery mechanisms employed rely on chance for the successful delivery of genetic information, such as RNA, into the plastid genome.
- Prior art methods do not rely on efficient endogenous cellular processes for the transfer of RNA into the plastid genome, subsequent reverse transcription and recombination of it within the plastid genome, and where desired, followed by expression of protein of interest therefrom. As such, prior art processes for genetically modifying plastids appear inefficient.
- the present inventors have found that by using or adapting endogenous cellular processes for the transfer of polynucleotide sequences, such as RNAs, from the cytoplasm to the plastid in the plant cell, polynucleotide sequences derived from nuclear transformation of the nucleus of a plant cell can be efficiently transferred or targeted to the plastid genome within a plant cell that is so transformed, and expressed more efficiently in the plastid as described herein. Furthermore, it is apparent that once the plastid is transformed with sequences of the invention, it is not necessary for the nuclear encoded trangenes that are required for the initial transformation of the plastid to remain in the nuclear genome.
- the nuclear encoded transgenes can be removed through deliberate or natural segregation in subsequent generations of plants.
- the terms "plastid” and “plastids” and “plastid population” are used interchangeably, as are the terms “plant cell” and “plant cells”, unless context demands otherwise.
- RNA that is derived from the nucleus of the cell is constantly bombarded by RNA that is derived from the nucleus of the cell, which is carried over the plastid membrane and into the plastid where it is reverse transcribed, integrated into the genome and then transcribed, resulting in the generation of RNA from which proteins of interest may be expressed.
- a plant plastid transformation unit comprising nucleic acid sequences that encode: i) a plant plastid transformation unit (PTU) ; ii) a reverse transcriptase fused to a plant-derived chloroplast transit peptide sequence; and iii) an RNA binding protein fused to a plant plastid transit peptide.
- PTU plant plastid transformation unit
- plant plastid transformation unit examples include those that comprise nucleic acid sequences that encode i) a plant plastid transformation unit [PTU, for example, a chloroplast transformation unit (CTU) ] ; a plant plastid translocation sequence (PPS-5' ) , for example, a chloroplast translocation sequence (CTS-5' ) , fused to the 5' end of the PTU; a further plant plastid translocation sequence (PPS-3' ) , for example a chloroplast translocation sequence (CTS-3' ) fused to the 3'- end of the CTU; and a primer binding domain designed for reverse transcription in plastids using plastid tRNA-Met, such as chloroplast tRNA-Met (PBD-CHL) .
- PTU a chloroplast transformation unit
- PPS-5' plant plastid translocation sequence
- CTS-5' chloroplast translocation sequence
- CTS-3' chloroplast translocation sequence
- the LtrA protein is able to function as both a translocation protein and as a source of reverse transcriptase. In such a variant, there is no need to introduce a second gene for reverse transcriptase functionality.
- the PBD may be located adjacent to the 3' -end of the PTU (or preferably, a CTU) and a plastid translocation sequence, preferably a chloroplast translocation sequence, is fused to it downstream.
- a PBD is employed that is able to bind with cytoplasmic tRNA-Met as primer, reverse transcription is initiated by endogenous reverse transcriptase in the cytoplasm using cytoplasmic tRNA-Met.
- the second variant of the system does not require the co-delivery of a reverse transcriptase nucleic acid sequence to the plastids, such as chloroplasts .
- plastids such as chloroplasts .
- the use of such plastid transformation systems provides for an improved yield of RNA and hence protein of interest from plastid sources than has been hitherto achievable in the prior art.
- a method of transforming a plant cell that comprises:
- nucleic acid sequence that comprises a plant nuclear promoter operably linked to a first nucleic acid sequence that comprises a plastid transgene cassette, a plastid translocation sequence (PTS), and a primer binding domain (PBD) ; 2) introducing into the said plant cell a second nucleic acid sequence that encodes for a plastid translocation sequence binding protein fused to a first plastid transit peptide (PTSBP-TP) wherein said second nucleic acid sequence is operably linked to a plant nuclear promoter; and
- plastid for the purposes of the present invention encompasses chloroplasts, proplastids, etioplasts, chromoplasts, amyloplasts, leucoplasts and elaioplasts.
- plastid refers to chloroplasts.
- the method of the invention for transforming a plant cell comprises :
- nucleic acid sequence that comprises a plant nuclear promoter operably linked to a first nucleic acid sequence that comprises a plastid transgene cassette, a plastid translocation sequence (PTS) , and a primer binding domain (PBD); and
- the plastid transgene cassette is a chloroplast transgene cassette
- the plastid translocation sequence (PTS) is a chloroplast translocation sequence (CTS)
- the reverse transcriptase protein is a reverse transcriptase from a retrotransposon or a retrovirus which is fused to a chloroplast transit peptide for targeting into the chloroplast .
- a method of transforming a plant cell comprises introducing into the plant cell a nucleic acid sequence that comprises a plant nuclear promoter operably linked to a first nucleic acid sequence that comprises a first plastid translocation sequence (PTS-5' ) fused to the 5' -end of the plastid transgene unit (PTU), a second plastid translocation sequence (PTS-3' ) fused to the 3' end of the PTU, and a primer binding domain designed for reverse transcription in plastids, using tRNA-Met located within the plastids.
- PTS-5' first plastid translocation sequence fused to the 5' -end of the plastid transgene unit
- PTU plastid transgene unit
- PTS-3' second plastid translocation sequence
- the first plastid translocation sequence at the 5' -end is a chloroplast translocation sequence (CTS-5' ) , that is fused to a the 5' -end of a chloroplast transformation unit (CTU) , and a second plastid translocation sequence is fused to the 3' -end of the CTU.
- the second plastid translocation sequence is a chloroplast translocation sequence (CTS-3')that is fused to a primer binding domain that is designed for reverse transcription in chloroplast plastids (PBD-CHL) , using tRNA-Met as primer that are located within the chloroplasts .
- the two plastid translocation sequences may be the same or different depending on design.
- reverse transcription can be effected when the PBD is located downstream of the CTU, that is to say 3' to a chloroplast translocation sequence (CTS-3' ) .
- CTS-3' chloroplast translocation sequence
- a method of transforming a plant cell comprises introducing into the plant cell a nucleic acid sequence that comprises a plant nuclear promoter operably linked to a first nucleic acid sequence that comprises a first plastid translocation sequence (PTS-5' ) fused to the 5' -end of the plastid transgene unit (PTU), a second plastid translocation sequence (PTS-3' ) fused to the 3'- end of a primer binding domain for binding tRNA-Met as primer that uses tRNA-Met that is located within the cytoplasm.
- PTU plastid translocation sequence
- PTU plastid transgene unit
- the first plastid translocation sequence at the 5' -end is a chloroplast translocation sequence (CTS-5' ) , that is fused to the 5' -end of a chloroplast transformation unit (CTU) .
- the second plastid translocation sequence is a chloroplast translocation sequence (CTS-3' ) that is fused to a primer binding domain that is capable of utilising native, endogenous reverse transcriptase located in the cytoplasm (PBD-CYT) for reverse transcription using cytoplasmic tRNA-Met as primer.
- the two plastid translocation sequences may be the same or different depending on design. In this variant, there is also no need to co-deliver a nucleic acid sequence to the chloroplasts for reverse transcriptase functionality.
- a method of producing at least a heterologous or exogenous RNA species in a plant that comprises:
- nucleic acid sequence that comprises a plant nuclear promoter operably linked to a first nucleic acid sequence that comprises a plastid transgene cassette, a plastid translocation sequence (PTS) 7 and a primer binding domain (PBD) ;
- the plant obtained according to the above method is grown under conditions wherein the said heterologous or exogenous RNA species encoded by the transgene integrated into the plastid is expressed as heterologous or exogenous protein.
- step 2) of the said method may be omitted.
- a a method of producing at least a heterologous or exogenous RNA species in a plant that comprises:
- nucleic acid sequence that comprises a plant nuclear promoter operably linked to a first nucleic acid sequence that comprises a plastid transgene cassette, a plastid translocation sequence (PTS), and a primer binding domain (PBD) ;
- a method of producing at least a heterologous or exogenous RNA species in a plant that comprises:
- introducing into a regenerable plant cell a nucleic acid sequence that comprises a plant nuclear promoter operably linked to a first nucleic acid sequence that comprises a first plastid translocation sequence (PTS-5' ) fused to the 5' -end of the plastid transgene unit (PTU) , a second plastid translocation sequence
- PTS-3' fused to the 3' -end of the PTU, and a primer binding domain designed for reverse transcription in plastids;
- the first plastid translocation sequence at the 5' -end is a chloroplast translocation sequence (CTS-5' ) , that is fused to the 5' -end of a chloroplast transformation unit (CTU), and a second plastid translocation sequence is fused to the 3' -end of the CTU.
- the second plastid translocation sequence is a chloroplast translocation sequence (CTS-3')that is fused to a primer binding domain that is designed for reverse transcription in chloroplast plastids (PBD-CHL) , using tRNA-Met as primer that are located within the chloroplasts .
- the two plastid translocation sequences may be the same or different depending on design.
- a method of producing at least a heterologous or exogenous RNA species in a plant that comprises:
- nucleic acid sequence that comprises a plant nuclear promoter operably linked to a first nucleic acid sequence that comprises a first plastid translocation sequence (PTS-5') fused to the 5' -end of the plastid transgene unit (PTU), a second plastid translocation sequence (PTS-3' ) fused to the 3'- end of a primer binding domain for binding tRNA-Met as primer that uses tRNA-Met that is located within the cytoplasm.
- PTS-5' first plastid translocation sequence
- PTU plastid transgene unit
- the first plastid translocation sequence at the 5' -end is a chloroplast translocation sequence (CTS-5' ) , that is fused to the 5' -end of a chloroplast transformation unit (CTU) .
- the second plastid translocation sequence is a chloroplast translocation sequence (CTS-3' ) that is fused to a primer binding domain that is capable of utilising native, endogenous reverse transcriptase located in the cytoplasm (PBD-CYT) for reverse transcription using cytoplasmic tRNA-Met as primer.
- the two plastid translocation sequences may be the same or different depending on design.
- plant nuclear promoter by being operably linked to the nucleic acid sequences provided for herein drives expression of such sequences in the plant nucleus.
- the "plastid transgene cassette” comprises a left flanking sequence (LFS) and a right flanking sequence (RFS) which are used for homologous recombination of the cassette into the plastid genome.
- LFS left flanking sequence
- RFS right flanking sequence
- plastid specific promoter sequence such as a chloroplast specific promoter, e.g. Prrn
- plastid specific terminator sequence such as a chloroplast specific terminator, e.g. 3'UTR sequence of psbA gene from tobacco
- the LFS and RFS may include the chloroplast specific promoter and terminator sequences, respectively, if for example, the isolated nucleic acid of interest is fused to a native chloroplast nucleic acid of interest.
- the promoter and the terminator sequences are not necessarily included within the LFS or RFS, respectively per se, or between the LFS and RFS if a transgene is inserted into the chloroplast genome as a cistron unit or if a transgene is translationally fused to a native gene.
- transgene when a transgene is fused to a native chloroplast coding sequence it is after the transformation event has taken place that the promoter may be found upstream of the sequence that is homologous to the LFS in the chloroplast genome and is available to drive expression of the gene fused to the transgene of interest.
- transgene includes isolated nucleic acid sequences that may ultimately give rise to the expression of proteins or peptides of interest in the plastid (e.g. chloroplast) as herein described.
- the isolated nucleic acid sequence may be one that gives rise to an RNA sequence of interest which may not encode or give rise to the expression of a translatable product, or the isolated nucleic acid sequence may give rise to an RNA sequence that does encode or give rise to the expression of a translatable product such as a protein or peptide of interest.
- a translatable product such as a protein or peptide of interest.
- the transgene that is carried on the isolated nucleic acid may also be designed to give rise to an RNA sequence that gives rise to the expression of a translatable product or products, and untranslatable RNAs.
- RNAs that do not give rise to the expression of proteins may give rise to RNA sequences that contain deletions or other mutations and these may find use as research tools for studying gene function in the plastid, e.g. chloroplast.
- suitable transgenes of interest include plant proteins capable of conferring desired traits to plant crops, and pharmaceutical proteins for use in mammals, including man, such as insulin, preproinsulin, proinsulin, glucagon, interferons such as ⁇ -interferon, ⁇ - interferon, ⁇ -interferon, blood-clotting factors selected from Factor VII, VIII, IX, X, XI, and XII, fertility hormones including luteinising hormone, follicle stimulating hormone growth factors including epidermal growth factor, platelet-derived growth factor, granulocyte colony stimulating factor and the like, prolactin, oxytocin, thyroid stimulating hormone, adrenocorticotropic hormone, calc
- the method of the invention can be used for the production of specific monoclonal antibodies or active fragments thereof and of industrial enzymes or active fragments thereof .
- proteins mentioned hereinabove are of the plant and human type.
- Other proteins that are contemplated for production in the present invention include proteins for use in veterinary care and may correspond to animal homologues of human proteins, such as the human proteins mentioned hereinabove.
- a plant cell that comprises plastids, such as chloroplasts, that are permanently transformed with an exogenous or a heterologous nucleic acid sequence that encodes for a protein or RNA of interest. Suitable proteins and peptides and nucleic acids of interest are provided herein.
- the LFS and RFS may be selected from any nucleotide sequences that may be used for homologous recombination in the plastid. Suitable examples include coding sequences such as the sequence coding for psbA, rbcL genes from chloroplasts.
- the plant plastid promoter may be selected from the group consisting of the RNA polymerase promoter, rpo B promoter element, atpB promoter element, the clpP promoter element, the 16S rDNA promoter element, PrbcL, Prpsl ⁇ , the Prrnl ⁇ , Prrn-62, Pycf2-1577, PatpB-289, Prps2-152, Prpsl ⁇ -107, Pycfl-41, PatpI-207, PclpP-511, PclpP-173, PaccD-129, PaccD-129 promoter of the tobacco accD gene, the PclpP-53 promoter of the clpP gene, the Prrn-62 promoter of the rrn gene, the Prpsl6-107 promoter of the rpsl ⁇ gene, the PatpB/E-290 promoter of the tobacco atpB/E gene, and the PrpoB-345 promoter of the rpoB
- promoters which belong to class III Hajdukiewicz P T J et al. (1997) EMBO J 16:4041-4048) and all fragments of the class II promoters which control the initiation of transcription by NEP may be utilized in the method of the invention.
- Such promoters or promoter moieties are not generally known to be highly conserved.
- ATAGAATAAA is given as consensus near the transcription initiation site of NEP promoters (Hajdukiewicz P T J et al (1997) EMBO J 16:4041-4048) .
- the plant plastid terminator such as a chloroplast transcription terminator may be selected from any plastid terminator such as psbA, atpA, rbcL 3'-UTR region, and bacterial transcription terminators such as rrnB described by Orosz A., et al . , Eur. J. Biochemistry, 2005, Volume 201, Issue 3, pp 653-659.
- a chloroplast transcription terminator may be selected from any plastid terminator such as psbA, atpA, rbcL 3'-UTR region, and bacterial transcription terminators such as rrnB described by Orosz A., et al . , Eur. J. Biochemistry, 2005, Volume 201, Issue 3, pp 653-659.
- rrnB described by Orosz A., et al . , Eur. J. Biochemistry, 2005, Volume 201, Issue 3, pp 653-659.
- other terminator DNA sequences may
- the plant plastid (e.g. chloroplast) transgene cassette also comprises a primer binding domain (PBD) that once inside the plastid (e.g. chloroplast) is able to capture tRNAs as primers to form template RNA to initiate reverse transcription of introduced plant chloroplast transformation units of the invention.
- a suitable tRNA for use in the present invention as a primer is tRNA- fMet which forms a template RNA ready for reverse transcription.
- PBDs are found naturally on retroelements including retroviruses and retrotransposons .
- PBDs comprise specific RNA domains that anneal to specific sequences on tRNA molecules.
- the tRNA itself does not serve as a PBD but as a primer for reverse transcription, the template for reverse transcription is the RNA molecule that carries a PBD.
- Novel PBDs can be readily engineered that can anneal to other tRNAs.
- PBDs can be designed to bind other types of tRNAs such as, tRNA-lys and tRNA-Met of tobacco and others which are known in the art (http: //www. unibayreuth.de/departments/biochemie/trna/) .
- retroelements such as retroviruses or retrotransposons
- PBDs possessing conserved domains that anneal with complementary domains from tRNA (usually tRNA- met, or tRNA-trp) ; because of the conserved structures of all tRNAs (the so-called clover-leaf structure) , PBDs can be engineered so that they carry specific domains that will anneal with a tRNA of choice.
- a "plastid translocation sequence” (PTS, for example a chloroplast translocation sequence (CTS)) is an RNA sequence that is capable of being bound to a plant PTS binding protein and thereby, the PTS and other RNA sequences that may be associated with it or fused with it can be transported across and into the plastid (e.g. chloroplast) .
- CTS chloroplast translocation sequence
- the CTS can be selected from naked RNA viruses, including viral RNAs such as those from positive stranded RNA viruses such as potato virus X (PVX) , tobacco mosaic virus (TMV) , tomato mosaic virus (ToMV) , and viral RNAs from negative stranded RNA viruses, such as tomato spotted wilt virus (TSWV) and Impatiens necrotic spotted virus (INSV) , viroids such as peach latent mosaic viroid (PLMVd) or avocado sunblotch viroid (ASBV) , satellite viruses such as satellite tobacco mosaic virus (STMV) and the like.
- viral RNAs such as those from positive stranded RNA viruses such as potato virus X (PVX) , tobacco mosaic virus (TMV) , tomato mosaic virus (ToMV) , and viral RNAs from negative stranded RNA viruses, such as tomato spotted wilt virus (TSWV) and Impatiens necrotic spotted virus (INSV) , viroids such
- PTS/CTS include group I and group II intron RNAs or modified versions thereof in which cryptic splicing sites have been eliminated that may be derived from a bacterium, a fungus or a plastid/chloroplast from a plant, such as an LTRB intron lacking the sequence coding for LTRA (the protein encoded by an LTRA sequence being capable of serving as an PTS/CTS-binding protein in the method of the invention) .
- the intron is a group II intron, such as the Lactococcus lactis Ll . ltrB intron or a modified version of it in which cryptic splicing sites have been eliminated as outlined herein.
- Group II introns are widely represented in the organelles of plants and fungi, and in bacteria.
- Group II introns useful in the method of the invention are mobile, highly structural retroelements that encode multifunctional protein (intron encoded protein or IEP) which possesses reverse transcriptase (RT) activity.
- the IEP facilitates splicing of intron RNA by stabilization of the catalytically active RNA structure, performs reverse transcription and insertion of the intron into specific DNA target sites of the bacterial genome at high frequency (Moran et al. (1995) MoI Cell Biol 15:2828-2838; Cousineau et al . (1998) Cell 94:451-462) .
- Group II introns of bacterial origin such as those derived from Lactococcus that comprise a modified LtrA gene, are preferably used in the method of the invention.
- the LtrA polynucleotide sequence of a Lactococcus bacterium, such as Lactococcus lactis may be modified for optimum expression in plants by inserting into it at least one polynucleotide sequence comprising one or more, introns from at least one plant nucleic acid sequence, such as from one or more plant genes and by substituting certain selected codons having a low frequency of usage in native plants with codons that occur with a higher frequency in such plants.
- the bacterial LtrA sequence of interest is analysed with reference to plant codon usage using in silico comparisons such as those found at the website www.kazusa.or.jp/codon for bacterial codons that occur with low frequency in plants. Such codons may then be substituted with codons that have a high frequency of occurrence in plants, and an in silico-derived modified polynucleotide sequence is generated. From this optimised LtrA sequence a synthetic LtrA polynucleotide sequence corresponding to the in silico generated sequence is made using standard polynucleotide synthesis procedures known in the art, and may then be used in the preparation of constructs of use in the present invention as outlined herein. It is thought that by using a modified sequence that comprises plant codon substitutions as outlined above more plant cell environment stable polynucleotide RNA sequences are generated.
- introns that may be used in the method of the invention include, for example, the group I intron from Tetrahymena (GenBank Ace. No. : X54512; Kruger K et al. (1982) Cell 31:147-157; Roman J and Woodson S A (1998) Proc Natl Acad Sci USA 95:2134-2139), the group II rll intron from Scenedesmus obliquus (GenBank Ace. No.: X17375.2 nucleotides 28831 to 29438; Hollander V and Kuck U (1999) Nucl Acids Res 27: 2339-2344; Herdenberger F et al. (1994) Nucl Acids Res 22: 2869-2875; Kuck U et al. (1990) Nucl Acids Res 18:2691-2697), and the Ll.LtrB intron (GenBank Ace. No. : U50902 nucleotides 2854 to 5345) .
- endogenous introns that occur naturally in the plastid for example, in the chloroplast, such as group II introns from plant chloroplasts, for example the atpF, rpl, trnA, trnl, trnK, petD, petB (Jenkins B. D. et al., The Plant Cell, Vol. 9, 283-296, March 1997) .
- Introns which occur naturally in the plastids such as chloroplasts of the plant of interest may be modified such that they have a sequence homology of about 50%, 60%, 70%, 75%, 80%, 85%, 90% or 95%, or of any percentage sequence homology therebetween, with the sequence of the starting intron, while retaining functionality, may also be employed in the method of the invention.
- Other MTS include RNA domains found on tobacco TNTl, yeast TyI- and Ty3-like retrotransposons or other RNA that harbours a domain that is recognised by an RNA binding protein that is driven into the chloroplasts .
- a "plastid translocation sequence binding protein” (PTS-BP, for example, a CTS-BP) can be any RNA binding protein that recognises and binds to specific RNA domains of interest and is fused to a plastid transit peptide, such as a chloroplast transit peptide.
- TP plant chloroplast transit peptide
- rbcS small subunit of Rubisco
- HSP70 proteins Marshall & Keegstra (1992) Plant Physiology, 100, 1048- 1054
- those that may be predicted by chloroplast localisation sequences programmes http://www.psort.org) .
- the "reverse transcriptase” protein may be selected from a retrovirus source, such as from plant retroviruses such as SIRE-I from soybean, or from a retrotransposon source such as from the yeast TyIl retrotransposon, for example the reverse transcriptase-RNaseH domain (Goffeau et al., Science 274 (5287), 546-547 (1996) ) or the tobacco TnTl retrotransposon (RTRH domain) (Vernhettes et., al.; MoI. Biol. Evol . 15 (7), 827-836 (1998)) .
- a retrovirus source such as from plant retroviruses such as SIRE-I from soybean
- a retrotransposon source such as from the yeast TyIl retrotransposon
- the reverse transcriptase-RNaseH domain Gibre transcriptase-RNaseH domain
- RTRH domain tobacco TnTl retrotransposon domain
- a plant nuclear promoter (for example, an exogenous nucleus specific promoter) is one that is able to drive expression of a nucleic acid sequence such as a cDNA sequence or a full length gene sequence in the nucleus of a plant cell, forming a transcribed RNA sequence.
- the plant nuclear promoter is one that is introduced in front of a nucleic acid sequence of interest and is operably associated therewith.
- a plant nuclear promoter is one that has been placed in front of a selected polynucleotide component.
- a plant nuclear promoter, such as an exogenous nucleus specific promoter is one that is transferred to a host cell or host plant from a source other than the host cell or host plant.
- the cDNAs encoding a polynucleotide of the invention contain at least one type of nucleus specific promoter that is operable in a plant cell, for example, an inducible or a constitutive promoter operatively linked to a first and/or second nucleic acid sequence or nucleic acid sequence component as herein defined and as provided by the present invention. As discussed, this enables control of expression of polynucleotides of the invention.
- the invention also provides plants transformed with polynucleotide sequences or constructs and methods including introduction of such polynucleotide nucleic acid sequences or constructs into a plant cell and/or induction of expression of said first or second nucleic acid sequence or construct within a plant cell, e.g. by application of a suitable stimulus, such as an effective exogenous inducer .
- inducible as applied to a promoter is well understood by those skilled in the art. In essence, expression under the control of an inducible promoter is "switched on” or increased in response to an applied stimulus (which may be generated within a cell or provided exogenously) . The nature of the stimulus varies between promoters. Some inducible promoters cause little or undetectable levels of expression (or no expression) in the absence of the appropriate stimulus. Other inducible promoters cause detectable constitutive expression in the absence of the stimulus. Whatever the level of expression is in the absence of the stimulus, expression from any inducible promoter is increased in the presence of the correct stimulus.
- an inducible (or “switchable” ) promoter may be used which causes a basic level of expression in the absence of the stimulus which level is too low to bring about a desired phenotype (and may in fact be zero) .
- expression is increased (or switched on) to a level, which brings about the desired phenotype.
- an inducible promoter is the ethanol inducible gene switch disclosed in Caddick et al (1998) Nature Biotechnology 16: 177-180. A number of inducible promoters are known in the art.
- Chemically regulated promoters can be used to modulate the expression of a gene or a polynucleotide sequence of the invention in a plant through the application of an exogenous chemical regulator.
- the promoter may be a chemically inducible promoter, where application of the chemical induces gene expression, or a chemical-repressible promoter, where application of the chemical represses gene expression.
- Chemically inducible promoters are known in the art and include, but are not limited to, the maize In2-2 promoter, which is activated by benzenesulfonamide herbicide safeners, the maize GST promoter, which is activated by hydrophobic electrophilic compounds that are used as pre-emergent herbicides, and the tobacco PR-la promoter, which is activated by salicylic acid.
- Other chemically regulated promoters of interest include steroid-responsive promoters (see, for example, the glucocorticoid-inducible promoter in Schena et al. (1991) Proc. Natl. Acad. Sci. USA 38:10421-10425 and McNellis et al. (1998) Plant J.
- tissue-specific promoters include those described by Yamamoto et al. (1997) Plant J. 12 (2) 255-265; Kawamata et al. (1997) Plant Cell Physiol. 38(7) :792-803; Hansen et al. (1997) MoI. Gen Genet. 254(3) :337- 343; Russell et al. (1997) Transgenic Res. 6 (2) :157-168 ; Rinehart et al. (1996) Plant Physiol. 112 (3) : 1331-1341; Van Camp et al. (1996) Plant Physiol. 112 (2) : 525-535; Canevascini et al. (1996) Plant Physiol.
- constitutive promoters may also be used in the methods of the present invention.
- Constitutive promoters include, for example, CaMV 35S promoter (Odell et al. (1985) Nature 313:810- 812) ; rice actin (McElroy et al. (1990) Plant Cell 2:163-171) ; ubiquitin (Christensen et al. (1989) Plant MoI. Biol. 22:619-632 and Christensen et al. (1992) Plant MoI. Biol. 18:675-689); pEMU (Last et al. (1991) Theor. Appl. Genet. 81:581-588); MAS (Velten et al. (1984) EMBO J.
- the plant nuclear promoter used in the method of the invention is a constitutive promoter.
- the expression in the plastid is effected by employing a plant plastid promoter such as plastid specific promoters and/or transcription regulation elements.
- a plant plastid promoter such as plastid specific promoters and/or transcription regulation elements.
- a plant plastid promoter such as plastid specific promoters and/or transcription regulation elements.
- a plant plastid promoter such as plastid specific promoters and/or transcription regulation elements.
- a plant plastid promoter such as plastid specific promoters and/or transcription regulation elements.
- a plant plastid promoter such as plastid specific promoters and/or transcription regulation elements.
- promoters such as plastid specific promoters and/or transcription regulation elements.
- promoters such as plastid specific promoters and/or transcription regulation elements.
- promoters such as plastid specific promoters and/or transcription regulation elements.
- promoters such as
- the plastid specific promoter may also have a polycistronic "operon" assigned to it (EP-A 1 076 095; WO 00/20611) .
- Further promoters that may be used in the method of the invention also include the PrbcL promoter, the Prpsl ⁇ promoter, and the Prrnl6 promoter described in US Patent application 2006/0253916, the plastid specific promoters Prrn-62, P ⁇ cf2-1577, PatpB-289, Prps2-152, Prpsl6-107, Pycfl-41, PatpI-207, PclpP-511, PclpP-173 and PaccD-129 (WO 97/06250; Hajdukiewicz P T J et al.
- a terminator is contemplated as a DNA sequence at the end of a transcriptional unit which signals termination of transcription. These elements are 3' -non-translated sequences containing polyadenylation signals, which act to cause the addition of polyadenylate sequences to the 3' end of primary transcripts.
- the nopaline synthase transcriptional terminator (A. Depicker et al., 1982, J. of MoI. & Applied Gen. 1:561-573) sequence serves as a transcriptional termination signal.
- a plastid transformation sequence that comprises: i) a plant plastid translocation sequence; ii) a plastid transgene cassette; and iii) a primer binding domain.
- the plant plastid translocation sequence and the primer binding domain are as defined herein.
- the plastid transgene cassette comprises a left flanking sequence (LFS) and a right flanking sequence (RFS) as herein described, and may include a promoter region and/or a terminator region sourced from a higher or lower plant plastid, such as a chloroplast, for example from tobacco, arabidopsis, brassica sp., potato, corn (maize) , canola, rice, wheat, barley, brassica sp., cotton, algae (e.g. blue green species), lemnospora ("duckweed”), or moss (e.g. physcomitrella patens) .
- the promoter and terminator regions are sourced from higher plant species.
- LFS and RFS do not include a promoter and/or a terminator region
- these components may be placed adjacent to the LFS and/or RFS, as appropriate, or there may be a spacer region therein between.
- Included within the plastid transgene cassette is at least one transgene or one nucleotide sequence of choice that is destined to be transcribed and/or translated in the chloroplast in accordance with the design of the method of the present invention for example, for the production of desired protein(s), RNAs of interest, or knockout of endogenous plastidal genes and regulatory sequences.
- Suitable transgenes of interest contemplated for protein or peptide production in a method of the present invention include plant proteins and pharmaceutical proteins for use in mammals, including man, such as insulin, preproinsulin, proinsulin, glucagon, interferons such as ⁇ -interferon, ⁇ - interferon, ⁇ -interferon, blood-clotting factors selected from Factor VII, VIII, IX, X, XI, and XII, fertility hormones including luteinising hormone, follicle stimulating hormone growth factors including epidermal growth factor, platelet-derived growth factor, granulocyte colony stimulating factor and the like, prolactin, oxytocin, thyroid stimulating hormone, adrenocorticotropic hormone, calcitonin, parathyroid hormone, somatostatin, erythropoietin (EPO) , enzymes such as ⁇ -glucocerebrosidase, haemoglobin, serum albumin, collagen, insect toxic protein from Bacillus
- proteins mentioned hereinabove are of the plant and human type.
- Other proteins that are contemplated for production in the present invention include proteins for use in veterinary care and may correspond to animal homologues of human proteins, such as the human proteins mentioned hereinabove.
- a plant cell that comprises plastids, such as chloroplasts, that are permanently transformed with an exogenous or a heterologous nucleic acid sequence that encodes for a protein of interest.
- plastids such as chloroplasts
- Suitable proteins and peptides of interest may be selected from those provided herein.
- nuclear terminator DNA sequences will be present in constructs used in the methods of the invention, these are contemplated as comprising a DNA sequence at the end of a transcriptional unit which signals termination of transcription. These elements are 3' -non-translated sequences containing polyadenylation signals, which act to cause the addition of polyadenylate sequences to the 3' end of primary transcripts.
- the nopaline synthase transcriptional terminator (A. Depicker et al . , 1982, J. of MoI. & Applied Gen. 1:561-573) sequence serves as a transcriptional termination signal .
- Suitable vectors can be chosen or constructed, containing appropriate regulatory sequences, including promoter sequences, terminator fragments, polyadenylation sequences, enhancer sequences, marker genes and other sequences as appropriate.
- appropriate regulatory sequences including promoter sequences, terminator fragments, polyadenylation sequences, enhancer sequences, marker genes and other sequences as appropriate.
- Molecular Cloning a Laboratory Manual: 2nd edition, Sambrook et al, 1989, Cold Spring Harbor Laboratory Press.
- Many known techniques and protocols for manipulation of nucleic acid for example in preparation of nucleic acid constructs, mutagenesis, sequencing, introduction of DNA into cells and gene expression, and analysis of proteins, are described in detail in Current Protocols in Molecular Biology, Second Edition, Ausubel et al.
- each introduced transgene in a transgene cassette will be under regulatory control of its own exogenous plastidal promoter, for example a chloroplast promoter and terminator.
- exogenous plastidal promoter for example a chloroplast promoter and terminator.
- Selectable genetic markers may facilitate the selection of transgenic plants and these may consist of chimaeric genes that confer selectable phenotypes such as resistance to antibiotics such as spectinomycin, streptomycin, kanamycin, neomycin, hygromycin, puramycin, phosphinotricin, chlorsulfuron, methotrexate, gentamycin, spectinomycin, imidazolinones and glyphosate .
- selectable phenotypes such as resistance to antibiotics such as spectinomycin, streptomycin, kanamycin, neomycin, hygromycin, puramycin, phosphinotricin, chlorsulfuron, methotrexate, gentamycin, spectinomycin, imidazolinones and glyphosate .
- nucleic acid to be inserted should be assembled within a construct, which contains effective regulatory elements, which will drive transcription. There must be available a method of transporting the construct into the cell. Once the construct is within the cell, integration into the endogenous chromosomal material either will or will not occur. Finally, as far as plants are concerned the target cell type must be such that cells can be regenerated into whole plants .
- Plants transformed with DNA segments containing sequences of interest as provided herein may be produced by standard techniques, which are already known for the genetic manipulation of plants.
- DNA can be transformed into plant cells using any suitable technology, such as a disarmed Ti-plasmid vector carried by Agrobacterium exploiting its natural gene transfer ability (EP- A-270355, EP-A-0116718, NAR 12(22) 8711 -87215 1984), particle or micro projectile bombardment (US 5100792, EP-A-444882, EP-A- 434616) microinjection (WO 92/09696, WO 94/00583, EP 331083, EP 175966, Green et al.
- a disarmed Ti-plasmid vector carried by Agrobacterium exploiting its natural gene transfer ability (EP- A-270355, EP-A-0116718, NAR 12(22) 8711 -87215 1984), particle or micro projectile bombardment (US 5100792, EP-A-444882, EP-A- 434616) microin
- Agrobacterium transformation is widely used by those skilled in the art to transform dicotyledonous species. Production of stable, fertile transgenic plants in almost all economically relevant monocot plants is also now routine: (Toriyama, et al. (1988) Bio/Technology 6, 1072-1074; Zhang, et al. (1988) Plant Cell Rep. 7, 379-384; Zhang, et al . (1988) Theor. Appl . Genet 76, 835-840; Shimamoto, et al. (1989) Nature 338, 274-276; Datta, et al . (1990) Bio/Technology 8, 736-740; Christou, et al.
- a combination of different techniques may be employed to enhance the efficiency of the transformation process, e.g. bombardment with Agrobacterium coated micro particles (EP-A-486234) or micro projectile bombardment to induce wounding followed by co-cultivation with Agrobacterium (EP-A- 486233) .
- a plant may be regenerated, e.g. from single cells, callus tissue or leaf discs, as is standard in the art. Almost any plant can be entirely regenerated from cells, tissues and organs of the plant. Available techniques are reviewed in Vasil et al., Cell Culture and Somatic Cell Genetics of Plants, Vol. I, II and III, Laboratory Procedures and Their Applications, Academic Press, 1984, and Weiss Bach and Weiss Bach, Methods for Plant Molecular Biology, Academic Press, 1989.
- the invention further encompasses a host cell transformed with vectors or constructs as set forth above, especially a plant or a microbial cell.
- a host cell such as a plant cell, including nucleotide sequences of the invention as herein indicated is provided.
- the nucleotide sequence may be incorporated within the chromosome.
- a plant cell having incorporated into its genome at least a nucleotide sequence, particularly heterologous nucleotide sequences, as provided by the present invention under operative control of regulatory sequences for control of expression as herein described.
- the coding sequence may be operably linked to one or more regulatory sequences which may be heterologous or foreign to the nucleic acid sequences employed in the invention, such as those not naturally associated with the nucleic acid sequence (s) for its (their) expression.
- the nucleotide sequence according to the invention may be placed under the control of an externally inducible promoter to place expression under the control of the user.
- a further aspect of the present invention provides a method of making such a plant cell involving introduction of nucleic acid sequence (s) contemplated for use in the invention or a suitable vector including the sequence (s) contemplated for use in the invention into a plant cell and causing or allowing recombination between the vector and the plant cell genome to introduce the said sequences into the genome.
- the invention extends to plant cells containing a nucleotide sequence according to the invention as a result of introduction of the nucleotide sequence into an ancestor cell.
- heterologous may be used to indicate that the gene/sequence of nucleotides in question have been introduced into said cells of the plant or an ancestor thereof, using genetic engineering, ie by human intervention.
- a transgenic plant cell i.e. transgenic for the nucleotide sequence in question, may be provided.
- the transgene may be on an extra-genomic vector or incorporated, preferably stably, into the genome.
- a heterologous gene may replace an endogenous equivalent gene, ie one that normally performs the same or a similar function, or the inserted sequence may be additional to the endogenous gene or other sequence.
- nucleotide sequences heterologous, or exogenous or foreign, to a plant cell may be non-naturally occurring in cells of that type, variety or species.
- a nucleotide sequence may include a coding sequence of or derived from a particular type of plant cell or species or variety of plant, placed within the context of a plant cell of a different type or species or variety of plant.
- nucleotide sequence to be placed within a cell in which it or a homologue is found naturally, but wherein the nucleotide sequence is linked and/or adjacent to nucleic acid which does not occur naturally within the cell, or cells of that type or species or variety of plant, such as operably linked to one or more regulatory sequences, such as a promoter sequence, for control of expression.
- a sequence within a plant or other host cell may be identifiably heterologous, exogenous or foreign.
- Plants which include a plant cell according to the invention are also provided, along with any part or propagule thereof, seed, selfed or hybrid progeny and descendants.
- transgenic crop plants which have been engineered to carry genes identified as stated above.
- suitable plants include tobacco ⁇ Nicotians tabacum) and other Nicotiana species, carrot, vegetable and oilseed Brassicas , melons, Capsicums, grape vines, lettuce, strawberry, sugar beet, wheat, barley, corn (maize), rice, soybean, peas, sorghum, sunflower, tomato, cotton, and potato.
- Especially preferred transgenic plants of the invention include cotton, rice, oilseed Brassica species such as canola, corn (maize) and soybean.
- the present invention provides any clone of such a plant, seed, selfed or hybrid progeny and descendants, and any part of any of these, such as cuttings, seed.
- the invention provides any plant propagule that is any part which may be used in reproduction or propagation, sexual or asexual, including cuttings, seed and so on.
- the present invention also encompasses the polypeptide expression product of a nucleic acid molecule according to the invention as disclosed herein or obtainable in accordance with the information and suggestions herein. Also provided are methods of making such an expression product by expression from a nucleotide sequence encoding therefore under suitable conditions in suitable host cells e.g. E.coli. Those skilled in the art are well able to construct vectors and design protocols and systems for expression and recovery of products of recombinant gene expression.
- the heterologous or exogenous target protein is contemplated to be any protein of interest that may be produced by the method of the invention.
- a polypeptide according to the present invention may be an allele, variant, fragment, derivative, mutant or homologue of the (a) polypeptides as mentioned herein.
- the allele, variant, fragment, derivative, mutant or homologue may have substantially the same function of the polypeptides alluded to above and as shown herein or may be a functional mutant thereof.
- “Homology” in relation to an amino acid sequence or polypeptide sequence produced by the method of the invention may be used to refer to identity or similarity, preferably identity. As noted already above, high level of amino acid identity may be limited to functionally significant domains or regions.
- Functionally significant domains or regions of different polypeptides may be combined for expression from encoding nucleic acid as a fusion protein.
- particularly advantageous or desirable properties of different homologues may be combined in a hybrid protein, such that the resultant expression product, may include fragments of various parent proteins, if appropriate.
- Similarity of amino acid sequences may be as defined and determined by the TBLASTN program, of Altschul et al. (1990) J. MoI. Biol. 215: 403-10, which is in standard use in the art.
- TBLASTN 2.0 may be used with Matrix BLOSUM62 and GAP penalties: existence: 11, extension: 1.
- Another standard program that may be used is BestFit, which is part of the Wisconsin Package, Version 8, September 1994, (Genetics Computer Group, 575 Science Drive, Madison, Wisconsin, USA, Wisconsin 53711) . BestFit makes an optimal alignment of the best segment of similarity between two sequences. Optimal alignments are found by inserting gaps to maximize the number of matches using the local homology algorithm of Smith and Waterman (Adv. Appl. Math.
- GAP Garnier et al. (1981) 2: 482- 489) .
- Other algorithms include GAP, which uses the Needleman and Wunsch algorithm to align two complete sequences that maximizes the number of matches and minimizes the number of gaps.
- GAP the Needleman and Wunsch algorithm to align two complete sequences that maximizes the number of matches and minimizes the number of gaps.
- a gap creation penalty of 3 and gap extension penalty of 0.1 may be used.
- FASTA which uses the method of Pearson and Lipman (1988) PNAS USA 85: 2444-2448) is a further alternative.
- FIG. 1 the major components of chloroplast transformation system.
- Transformation vector contains (i) chloroplast translocation sequence (CTS); (ii) chloroplast transgene cassette comprising left flanking sequence (LFS) and right flanking sequence (RFS) to facilitate insertion of the cassette into the chloroplast genome using homologous recombination, promoter region from tobacco chloroplast rrnl ⁇ gene (Prrn) , aacLA gene as a selectable marker
- aadA transcription terminator from chloroplast genome
- PBD primer binding domain
- rbcS-cTP Reverse Transcriptase- RNase H gene translationally fused to the chloroplast transit peptide from small subunit of tobacco Rubisco gene
- HSP60-cTP CTS-Binding peptide translationally fused to the chloroplast transit peptide from Arabidopsis HSP60 gene
- Figure 2 set of constructs used for chloroplast transformation in tobacco (ALG298, ALG327 and ALG 344) and in Arabidopsis (ALG347 and ALG327)
- the chloroplast transformation cassette contains left and right flanking sequences (LFS and RFS) , Prrn promoter (Prrn) , aadA gene for spectinomycin selection (aadA) , and rrnB transcription terminator (rrnB ter) .
- LFS and RFS left and right flanking sequences
- Prrn promoter Prrn
- aadA aadA gene for spectinomycin selection
- rrnB transcription terminator rrnB ter
- PBD Primer binding domain
- the resulting cassette was inserted within domain IV of LtrB (LtrB5' and LtrB3' ) intron from Lactococcus lactis (ALG298 and ALG347) or fused to chloroplast translocation sequence from Avocado sunblotch viroid
- the chloroplast transgene cassette was expressed from nuclear inserted cassette and resultant RNA was translocated into the chloroplast using LtrASi protein for vectors
- RNA was reverse transcriptase-RNaseH fused to chloroplast transit peptide (cTP- RTRH) from HSP60 gene (ALG327) .
- cTP- RTRH chloroplast transit peptide
- Ubiq3 Pro- Arabidopsis promoter from ubiquitin 3 gene; 35S Pro- promoter from Cauliflower Mosaic Virus 35S gene, TAF2 Pro- Arabidopsis promoter from TAF 2 gene; nos ter- transcription terminator from Agrobacterium nos gene.
- FIG. 3 modifications of the chloroplast transformation cassette were made by designing primer binding domain and positioning of building blocks on the transgene cassette.
- CTU- chloroplast transformation unit CTS-5' -chloroplast translocation sequence located at the 5' -end of the transformation cassette; CTS-3'- chloroplast translocation sequence located at the 3' -end of the transformation cassette; PDB-CHL- primer binding domain designed for reverse transcription in the chloroplasts using tRNA-Met from chloroplasts; PBD-CYT- primer binding domain designed for reverse transcription in the cytoplasm using cytoplasmic tRNA-Met.
- Example section IB The modifications detailed in Example section IB hereinafter and corresponding figures include a first modification of the use of PBD for the binding of cytoplasmic tRNA-Met as primer [Fig 3(C)] .
- CTS can be located at both the 5'- and 3'- ends of the transformation cassette, such as in the case with the LtrB intron.
- the transgene cassette is inserted inside of the LtrB intron (domain IV) .
- the PDB-CHL is located downstream of the LtrB 3' -end of the cassette (CTS-3'), so that the LtrA protein is able to function as both a translocation protein and reverse transcriptase.
- Figure 4 schematic presentation of constructs based on the LtrB- CTS for chloroplast transformation in tobacco .
- Figure 5 schematic presentation of constructs based on the LtrB- CTS for chloroplast transformation in rice .
- Figure 6 Schematic presentation of constructs based on ASB-CTS for chloroplast transformation in tobacco. Nos ter- nos transcription terminator, ASB- sequence from Avocado sunblotch viroid (ASBVd) as CTS, PBD-CHL- primer binding domain for chloroplast tRNA-Met, PDB- CYT- primer binding domain for cytoplasmic tRNA-Met, trnA flank- left flank of the transgene cassette, psbA ter- chloroplast transcription terminator from tobacco, mGFP- mGFP4 gene, aadA- aadA gene, Trrn- rrnl ⁇ chloroplast promoter from tobacco, trnl flank- right flank of transgene cassette, 35S Pro- 35S promoter from cauliflower mosaic virus (CaMV) , TAF2 Pro- promoter from Arabidopsis TAF2 gene, cTP- chloroplast transit peptide from rbcS gene of tobacco, RT-tyl- reverse transcripta
- Figure 7 PCR amplification of left flanking junction in tobacco transformed by the LtrB-CTS-based vectors .
- M- DNA marker M- DNA marker, 1-6- independent transgenic lines, wt- non- transgenic tobacco, NC- negative control without DNA.
- Figure 8 Southern hybridisation for tobacco transformed with ASB- CTS and LtrB-CTS based vectors .
- Expected size of wild type DNA band is ⁇ 1.3 kb, and band with transgene insertion ⁇ 3.6 kb .
- Chloroplast probe upstream of LFS was used as a probe.
- Figure 9 Northern analysis for tobacco plants transformed with LtrB-CTS based vector.
- aad-GFP DNA probe was used for hybridisation. Expected size of the band is ⁇ 1.5 kb .
- a new method for chloroplast transformation in plants comprises (1) a transformation vector consisting of 3 major domains: (i) chloroplast translocation sequence (CTS) , (ii) chloroplast transgene cassette, (iii) primer binding domain (PBD) which uses chloroplast tRNA-fMet or any other chloroplast tRNAs as a primer for reverse transcription;
- CTS chloroplast translocation sequence
- PBD primer binding domain
- RNase H Reverse Transcriptase- RNase H
- RNA binding protein that binds to chloroplast translocation sequence (CTS) of the transformation vector, fused to chloroplast transit peptide (Fig.l) .
- the process of chloroplast transformation comprises two steps: (1) Targeting of RNA-protein complex to the chloroplasts.
- RNA which contains the chloroplast translocation sequence (CTS) transgene cassette and primer binding domain (PBD) is achieved from the nuclear specific promoter.
- CTS binding protein (CTS-BP) fused to a chloroplast transit peptide will be also over-expressed on co-delivery from the same or a different vector and then will bind to the CTS, and facilitate translocation of the RNA into the chloroplasts.
- the chloroplast transformation vector Once the chloroplast transformation vector is presented in the plant cell via nuclear transformation, the chloroplast will then be permanently bombarded by the expressed CTS-BP-RNA complex. Such stable and continuous pumping of the complex into the targeted organelle is a prerequisite for achieving a high efficiency of organelle transformation.
- the technology exploits the finding that the chloroplast transit sequence is sufficient to permit the whole CTS-BP-RNA complex to be then taken up by the chloroplast.
- Chloroplast translocation sequence can be selected from a number of RNA sequences such as viroid RNA, groupl and groupll intron RNA, viral coat protein binding domains, retrotransposon primer binding sites, which are recognised by corresponding native RNA binding proteins.
- primer binding domain (PBD) of the vector RNA captures tRNA- fMet as a primer, and the over-expression of the reverse transcriptase (RT-RH) fused to the chloroplast transit peptide facilitates reverse transcription of RNA into single stranded DNA.
- R-RH reverse transcriptase
- Primer binding domain is designed to capture RT-RH protein and chloroplast tRNA- fMet (or other chloroplast tRNAs) as a primer, and initiate reverse transcription of chloroplast transgene cassette RNA into single-stranded DNA.
- the nuclear encoded transgenes are no longer required and they can then be removed through segregation in subsequent plant generations, leaving a clean organelle transformed plant line.
- CTS chloroplast translocation sequence
- LtrB intron from Lactococc ⁇ s lactis was synthesised by commercial DNA synthesis provider. Potential splicing sites were eliminated from this sequence as described in our previous patent. The domain for insertion of transgene cassette (Ascl-Mlul-Notl sites) is underlined and shown in bold letters.
- the chloroplast translocation sequence (CTL) from Avocado sunblotch viroid (Bank Accession No . J02020 ) was synthesised by PCR us ing the set of the following overlapping primers :
- chloroplast translocation sequence and chloroplast cassette fused to it was driven by 35S promoter from Cauliflower mosaic virus obtained by DNA synthesis
- the chloroplast transgene cassette contains left and right flanking sequences (LFS and RFS) for insertion of whole cassette into the chloroplast genome using homologous recombination, Prrnl ⁇ promoter region from tobacco, aadA gene as a selectable marker, and 3'UTR sequence of psbA gene as transcription terminator (Fig. D .
- LFS sequences for tobacco and Arabidopsis were amplified using the following PCR primers:
- RFS s equences were ampli fied us ing the following PCR primers : AS764 TGATATCGGATGGCCCTGCTGCGCCAGGGAAAAGAAT SEQ ID NO . 14 AS845 GCCGCGGATTGCCCTTCTCCGACCCTGAC SEQ ID NO.15
- Prrn promoter was amplified from tobacco genomic DNA cv. Petite Gerard using following PCR primers:
- Prrn-R ACTTGTATCGATGCGCTTCATATTCGCCCGGA SEQ ID NO.19 Prrnl6 promoter sequence
- aadA gene was synthesised by commercial DNA synthesis provider.
- Three introns from Arabidopsis gene At2g29890 were inserted into the coding sequence to optimise expression of the aadA in the cytoplasm of plant cells. The introns are underlined and shown in bold letters.
- the psbA 3'UTR terminator was amplified from the tobacco genomic DNA cv Petite Gerard using the following primers:
- Primer Binding Domain was designed as described by Friant et al., ((1998) MoI. Cellul. Biology, 18: 799-806) and amplified by PCR using the set of following overlapping primers:
- LtrA gene from Lactococcus lactis encoded by the LtrB intron was synthesised by commercial DNA synthesis provider.
- the sequence of the LtrA protein was first optimised for codon usage in plants and 5 plant introns were inserted into the coding sequence to improve LtrA expression in plants.
- Plant introns inserted in the coding sequence of LtrA gene are underlined and shown in bold letters .
- the introns 1,2 4 are from Arabidopsis gene At5g01290, intron 3 and 5 were selected from Arabidopsis gene At5g43940.
- the clone was named as LtrASi.
- LtrASi gene sequence LtrASi gene sequence :
- the 5' promoter region from Arabidopsis ubiquitin 3 gene was amplifies with the following primers:
- the nos teminator fragment was synthes ised based on gene bank sequence acces s ion EU048864 .
- the reverse trans criptase-RNase H gene from yeast Tyl-H3 clone ( Boe ke et al . , MoI . Cellul . Biology ( 1988 ) , 8 : 1432 - 1442 ; bank accession No . M18706 ) was optimised for codon usage in plants , and by insertion of 5 introns from Arabidops is genome ( intron 1 - from Atlg04820 , intron 2 - from At2g29550 , intron 3- from Atlg31810 , intron 4 and 5- from Atlg09170 ) . The introns are underlined and shown in bold letters .
- the clone was synthes i sed by commercial DNA synthesis provider and named as RTRHi-TyI .
- the RT-RH-TyI sequence was translationally fused to the chloroplast transit peptide from pea chloroplast HSP60 heat shock protein (Accession No. L03299) .
- the sequence for the transit peptide was amplified from pea genomic DNA using the following PCR primers:
- RTRHi-TyI and HSP60-cTP fusion were driven by TAF2 promoter from Arabidopsis taf2 gene. It was amplified from Arabidopsis genomic DNA (CoI-O) using the following set of primers :
- the agropine synthase polyA signal (ags terminator) was synthesized based on the gene bank sequence EU181145.
- Transformation of Arabidopsis plants was performed as described by Clough & Bent (Clough & Bent (1998) Plant Journal 16:735-743) .
- Agrobacterium tumefacience strain GV3101 Koncz & Schell (1986) MoI Gen Genet 204:383-396) was used for transformation. Transformation of plants was carried out with chloroplast transformation constructs ( Figure 2) based on the pGreen 0029 binary vector (Hellens et al (2000) Plant MoI. Biol 42: 819-832) .
- a chloroplast transformation cassette containing trnl flank, Prrn promoter, aadA gene, psbA 3' UTR, trnA flank and primer binding domain (PBD) was inserted into domain IV of the LtrB or fused to CTL from ASB using Ascl-Notl enzymes.
- the resulting DNA fragment was fused to the 35S promoter and nos terminator and introduced into the pGreen0029 binary vector (EU048864) .
- the fragment of LtrASi was fused to a chloroplast transit peptide (rbcS-cTP) and ubiq3 promoter from Arabidopsis .
- Resulting cassette was inserted into pGreen 0029 together with the chloroplast transformation cassette.
- the reverse transcriptase- RNase H (RTRHi-TyI) was fused to HSP60-cTP transit peptide, TAF2 promoter and ags terminator.
- the resulted cassette was inserted in pSOUP vector (EU048870) carrying T-DNA from pGreenO179 vector
- Transgenic lines were recovered on selection medium supplemented with lOOmg/1 of spectinomycin.
- Tobacco plants were transformed as described by Horsch et al., (1985) Science 227: 1229-1231, using Agrobacterium strain AGLl (see protocol, below) .
- constructs were similar to the constructs used for Arabidopsis transformation with exception that trnl and trnA flanking sequences of the chloroplast cassette were amplified from tobacco genomic DNA ( Figure 2) .
- Transgenic tobacco plants were regenerated on selection medium supplemented with 500 mg/1 of spectinomycin.
- Sterilize plant material take plants of about 9cm high, they should not have started to flower. Cut leaves with cuticle (4-6 leaves per construct, enough to cut 100 explants) , dip in 70% Ethanol and immediately dip in 1% Na-hypochlorite (cat. No 01032500; use bottle of bleach that is no more than 3 months old because the chlorine gas evaporates) , hold leaves with forceps and stir in for 20 min. Avoid damaging the cuticle otherwise bleach will enter the vascular system. Rinse briefly in sterile water 5-6 times and leave in water until ready to be cut.
- Co-cultivation of agro with tobacco explants grow AGLl in LB or L broth with appropriate antibiotics overnight at 28-30°C, the next day re-suspend agro in co-cultivation solution so that the final concentration is around 0.4-0.6 OD 6 oo nm - Place tobacco leaves in co- culture broth and cut squares of 1-1.5cm x 1-1.5cm with a rounded sterile scalpel using a rolling action.
- Transfer on selective TSM plates use sterile flamed forceps to pick up and wash explants in 100 mis co-cultivation broth supplemented with timentin 320mg/l (one pot per construct) , shake well, blot on sterile whatman paper and place the washed explants on selective TSM plates supplemented with appropriate selective antibiotics and timentin 320mg/l to kill agrobacterium.
- Root regeneration Takes around 1 week. Shoots are cut from the explants and place in growth boxes containing TRM supplemented with the appropriate selective antibiotics and timentin 320mg/l + cefotaxime 250mg/l to prevent agrobacterium recurrent growth.
- Adaptation to glasshouse conditions soak peat pellets in sterile water until they swell to normal size and carefully place one plant per pellet, incubate the plants under 100% humidity conditions in a propagator, gradually opening the little windows until plants adapt to normal atmosphere over several days.
- TRM ⁇ MS salts with vitamins and MES + 0.5% sucrose, pH5.7, 0.2% gelrite .
- Kanamycin 300mg/l (lOOmg/1 if using benthamiana)
- Hygromycin 30mg/l (lOmg/1 if using benthamiana)
- PPT 20mg/l (2mg/l if using benthamiana)
- Spectinomycin 500mg/l
- Timentin 320mg/l. It is used to kill agro, fairly unstable make up small amount of stock, store in freezer for up to 1 month after that the antibiotic is no more efficient.
- Cefotaxime 250mg/l. Also used to kill agro, add to TS
- Modifications of the chloroplast transformation method used in Experimental section IA can be improved using PBD designed for reverse transcription in the cytoplasm or in plastids, and by repositioning of the building blocks on the transformation cassette (Fig 3) .
- the PBD-CHL was designed as described previously.
- the primer binding domain of the tobacco tntl retrotransposon was used as the PBD-CYT, and it was amplified from genomic DNA of tobacco cv Petit Gerard using the following primers:
- the PBD-CHL was fused to the 3' end of the LtrB intron (Fig 3A, Fig 4A for tobacco and Fig 5A for rice) .
- LtrA protein possesses both LtrB-CTS-binding feature and reverse transcription activity it can fulfil both functions of the transgene RNA translocation into plastids and reverse transcription of the RNA cassette using plastid tRNA-Met as a primer .
- the PBD-CYT was fused to CTU (Fig 3B, Fig 4B for tobacco and Fig 5B for rice) , so that reverse transcription of the transgene cassette is initiated and performed by endogenous reverse transcriptases in the cytoplasm using cytoplasmic tRNA- Met.
- the LtrA protein serves as CTS-binding peptide for translocation of RNA: DNA complex initiated by the reverse transcriptases into the plastids.
- the ASB-CTS was fused to the CTU with PBD-CHL or PDB-CYT (Fig3, C- D, Fig 6, A and B) .
- the reverse transcriptase from yeast tyl retrotransposon was co-delivered with construct containing PBD-CHL to facilitate reverse transcription reaction in the plastids.
- the chloroplast cassette for rice transformation was designed using rice-specific sequences (Fig 5) .
- the trnl fragment of the rice chloroplast genome was utilised as the LFS, and it was amplified using the following primers:
- the trnA fragment of the rice chloroplast genome was used as the RFS, and it was amplified using following primers:
- the chloroplast-specific rrnl ⁇ promoter from wheat cv. Pavon was amplified using PCR with the following primers:
- the LtrA gene was driven by actinl rice promoter amplified using the following primers: ARPl gtcattcatatgcttgagaaga SEQ ID NO.77
- Immature Embryo Excision Day 1 Remove milky/post-milky stage immature seeds from panicles (immature embryos 1-2 mm in size are desired) .
- Regeneration After 40 to 60 days, transfer established embryogenic callus showing differential growth on proliferation medium + hygromycin to regeneration medium + hygromycin. Culture at 28eC under low light for 10 days then under high light for 10 additional days. Check plates periodically in the light for the development of embryos and green shoots. As shoots develop it is sometimes beneficial to gently move the developing shoot away from the callus it originated from and remove any dead tissue from the shoot itself to prevent inhibition of growth.
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Botany (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/131,004 US9567598B2 (en) | 2008-11-25 | 2009-11-25 | Plant plastid transformation method |
CA2781900A CA2781900C (en) | 2008-11-25 | 2009-11-25 | Polynucleotides for transforming a plastid in a plant cell, and for producing a cell or a plant containing the transformed plastid, and the method therefor |
EP09795795.5A EP2367942B1 (en) | 2008-11-25 | 2009-11-25 | Method for the transformation of plant cell plastids |
AU2009321351A AU2009321351B2 (en) | 2008-11-25 | 2009-11-25 | Method for the transformation of plant cell plastids |
ES09795795.5T ES2614499T3 (en) | 2008-11-25 | 2009-11-25 | Method for the transformation of plastidios of vegetal cells |
US15/407,685 US20170121724A1 (en) | 2008-11-25 | 2017-01-17 | Plant plastid transformation method |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0821516.2 | 2008-11-25 | ||
GB0821516.2A GB2465749B (en) | 2008-11-25 | 2008-11-25 | Plant cell transformation method |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/131,004 A-371-Of-International US9567598B2 (en) | 2008-11-25 | 2009-11-25 | Plant plastid transformation method |
US15/407,685 Continuation US20170121724A1 (en) | 2008-11-25 | 2017-01-17 | Plant plastid transformation method |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010061186A2 true WO2010061186A2 (en) | 2010-06-03 |
WO2010061186A3 WO2010061186A3 (en) | 2010-07-22 |
Family
ID=40230793
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2009/002754 WO2010061186A2 (en) | 2008-11-25 | 2009-11-25 | Plant plastid transformation method |
Country Status (7)
Country | Link |
---|---|
US (2) | US9567598B2 (en) |
EP (1) | EP2367942B1 (en) |
AU (1) | AU2009321351B2 (en) |
CA (1) | CA2781900C (en) |
ES (1) | ES2614499T3 (en) |
GB (1) | GB2465749B (en) |
WO (1) | WO2010061186A2 (en) |
Cited By (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011034946A1 (en) | 2009-09-15 | 2011-03-24 | Metabolix, Inc. | Generation of high polyhydroxybutrate producing oilseeds |
WO2012037324A2 (en) | 2010-09-15 | 2012-03-22 | Metabolix, Inc. | Increasing carbon flow for polyhydroxybutyrate production in biomass crops |
WO2013064119A1 (en) | 2011-11-03 | 2013-05-10 | The University Of Hong Kong | Methods using acyl-coenzyme a-binding proteins to enhance drought tolerance in genetically modified plants |
CN104585020A (en) * | 2015-01-15 | 2015-05-06 | 福建农林大学 | Breeding method of purple-leaf erect panicle type giant embryo glutinous rice variety |
EP3009511A2 (en) | 2015-06-18 | 2016-04-20 | The Broad Institute, Inc. | Novel crispr enzymes and systems |
WO2016164810A1 (en) | 2015-04-08 | 2016-10-13 | Metabolix, Inc. | Plants with enhanced yield and methods of construction |
WO2016205749A1 (en) | 2015-06-18 | 2016-12-22 | The Broad Institute Inc. | Novel crispr enzymes and systems |
WO2016205764A1 (en) | 2015-06-18 | 2016-12-22 | The Broad Institute Inc. | Novel crispr enzymes and systems |
WO2017070605A1 (en) | 2015-10-22 | 2017-04-27 | The Broad Institute Inc. | Type vi-b crispr enzymes and systems |
WO2017184786A1 (en) | 2016-04-19 | 2017-10-26 | The Broad Institute Inc. | Cpf1 complexes with reduced indel activity |
WO2017219027A1 (en) | 2016-06-17 | 2017-12-21 | The Broad Institute Inc. | Type vi crispr orthologs and systems |
WO2018045321A1 (en) * | 2016-09-02 | 2018-03-08 | North Carolina State University | Methods and compositions for modification of plastid genomes |
WO2018191388A1 (en) | 2017-04-12 | 2018-10-18 | The Broad Institute, Inc. | Novel type vi crispr orthologs and systems |
WO2019060746A1 (en) | 2017-09-21 | 2019-03-28 | The Broad Institute, Inc. | Systems, methods, and compositions for targeted nucleic acid editing |
US10273496B2 (en) | 2014-12-17 | 2019-04-30 | Basf Se | Plants with improved photosynthetic carbon fixation capacity |
WO2020033601A1 (en) | 2018-08-07 | 2020-02-13 | The Broad Institute, Inc. | Novel cas12b enzymes and systems |
WO2020131862A1 (en) | 2018-12-17 | 2020-06-25 | The Broad Institute, Inc. | Crispr-associated transposase systems and methods of use thereof |
WO2020191102A1 (en) | 2019-03-18 | 2020-09-24 | The Broad Institute, Inc. | Type vii crispr proteins and systems |
WO2020206046A1 (en) | 2019-04-01 | 2020-10-08 | The Broad Institute, Inc. | Methods and compositions for cell therapy |
WO2020236967A1 (en) | 2019-05-20 | 2020-11-26 | The Broad Institute, Inc. | Random crispr-cas deletion mutant |
WO2021041922A1 (en) | 2019-08-30 | 2021-03-04 | The Broad Institute, Inc. | Crispr-associated mu transposase systems |
US10968257B2 (en) | 2018-04-03 | 2021-04-06 | The Broad Institute, Inc. | Target recognition motifs and uses thereof |
US11591601B2 (en) | 2017-05-05 | 2023-02-28 | The Broad Institute, Inc. | Methods for identification and modification of lncRNA associated with target genotypes and phenotypes |
US11739308B2 (en) | 2017-03-15 | 2023-08-29 | The Broad Institute, Inc. | Cas13b orthologues CRISPR enzymes and systems |
WO2024113408A1 (en) * | 2022-11-28 | 2024-06-06 | 深圳大学 | Construction method for episome plasmids in chlamydomonas reinhardtii chloroplasts and use thereof |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2449466B (en) * | 2007-05-23 | 2009-11-18 | Algentech Ltd | Production of proteins in plant tissue |
CN108192901A (en) | 2012-02-01 | 2018-06-22 | 陶氏益农公司 | Artificial chloroplast transit peptides |
CN108699548A (en) * | 2015-11-16 | 2018-10-23 | 宾夕法尼亚州立大学托管会 | The therapeutic protein targeted delivery that biology is encapsulated in plant cell is to target cell type to treat disease |
US9896696B2 (en) | 2016-02-15 | 2018-02-20 | Benson Hill Biosystems, Inc. | Compositions and methods for modifying genomes |
US10570405B2 (en) | 2016-06-16 | 2020-02-25 | Nuseed Pty Ltd. | Elite event canola NS-B50027-4 |
WO2017218969A1 (en) | 2016-06-16 | 2017-12-21 | Nuseed Pty Ltd. | Inbred transgenic canola line ns-b50027-4 and seeds thereof |
CN106755085B (en) * | 2017-01-10 | 2020-05-12 | 中国农业科学院生物技术研究所 | Method for preparing salmon calcitonin |
CN107699588B (en) * | 2017-01-10 | 2020-05-08 | 中国农业科学院生物技术研究所 | Method for preparing salmon calcitonin |
JP7355730B2 (en) | 2017-08-09 | 2023-10-03 | ベンソン ヒル,インコーポレイティド | Compositions and methods for modifying the genome |
WO2021046526A1 (en) | 2019-09-05 | 2021-03-11 | Benson Hill, Inc. | Compositions and methods for modifying genomes |
WO2023119135A1 (en) | 2021-12-21 | 2023-06-29 | Benson Hill, Inc. | Compositions and methods for modifying genomes |
Citations (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0116718A1 (en) | 1983-01-13 | 1984-08-29 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Process for the introduction of expressible genes into plant cell genomes and agrobacterium strains carrying hybrid Ti plasmid vectors useful for this process |
EP0175966A1 (en) | 1984-09-25 | 1986-04-02 | Calgene, Inc. | Plant cell microinjection technique |
US4684611A (en) | 1982-02-11 | 1987-08-04 | Rijksuniversiteit Leiden | Process for the in-vitro transformation of plant protoplasts with plasmid DNA |
WO1987006614A1 (en) | 1986-04-30 | 1987-11-05 | Boyce Thompson Institute For Plant Research, Inc. | Electric field mediated dna transformation of plant cells and organelles |
EP0270355A2 (en) | 1986-12-03 | 1988-06-08 | Agracetus, Inc. | Genetic engineering of cotton plants and lines |
EP0290395A2 (en) | 1987-05-05 | 1988-11-09 | Sandoz Ag | Plant tissue transformation |
EP0331083A2 (en) | 1988-03-02 | 1989-09-06 | Schweizerische Eidgenossenschaft Eidgenössische Technische Hochschule (Eth) | Method for the production of transgenic plants |
WO1990012096A1 (en) | 1989-04-03 | 1990-10-18 | Purdue Research Foundation | Method for enhancing transmembrane transport of exogenous molecules |
EP0434616A1 (en) | 1989-12-19 | 1991-06-26 | Ciba-Geigy Ag | Method and appliance for the genetic transformation of cells |
DE4005152A1 (en) | 1990-02-17 | 1991-08-22 | Guenter Prof Dr Kahl | Transforming plant protoplast(s) with DNA-histone complex - providing high and reproducible transfer rate, and expression of foreign genes |
EP0444882A2 (en) | 1990-02-26 | 1991-09-04 | Agracetus, Inc. | Plant transformation process with early identificaton of germ line transformation events |
US5100792A (en) | 1984-11-13 | 1992-03-31 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues |
EP0486233A2 (en) | 1990-11-14 | 1992-05-20 | Pioneer Hi-Bred International, Inc. | Plant transformation method using agrobacterium species |
EP0486234A2 (en) | 1990-11-14 | 1992-05-20 | Pioneer Hi-Bred International, Inc. | Plant transformation method using agrobacterium species |
WO1992009696A1 (en) | 1990-11-23 | 1992-06-11 | Plant Genetic Systems, N.V. | Process for transforming monocotyledonous plants |
WO1992014828A1 (en) | 1991-02-14 | 1992-09-03 | Svalöf Ab | Method for genetic transformation of tissue organs from monocotyledonous plants |
US5268463A (en) | 1986-11-11 | 1993-12-07 | Jefferson Richard A | Plant promoter α-glucuronidase gene construct |
WO1994000583A1 (en) | 1992-06-23 | 1994-01-06 | South Dakota State University | Transformation of plants by direct injection of dna |
US5399680A (en) | 1991-05-22 | 1995-03-21 | The Salk Institute For Biological Studies | Rice chitinase promoter |
US5466785A (en) | 1990-04-12 | 1995-11-14 | Ciba-Geigy Corporation | Tissue-preferential promoters |
US5569597A (en) | 1985-05-13 | 1996-10-29 | Ciba Geigy Corp. | Methods of inserting viral DNA into plant material |
US5604121A (en) | 1991-08-27 | 1997-02-18 | Agricultural Genetics Company Limited | Proteins with insecticidal properties against homopteran insects and their use in plant protection |
WO1997006250A1 (en) | 1995-08-10 | 1997-02-20 | Rutgers University | Nuclear-encoded transcription system in plastids of higher plants |
US5608144A (en) | 1994-08-12 | 1997-03-04 | Dna Plant Technology Corp. | Plant group 2 promoters and uses thereof |
US5608142A (en) | 1986-12-03 | 1997-03-04 | Agracetus, Inc. | Insecticidal cotton plants |
US5608149A (en) | 1990-06-18 | 1997-03-04 | Monsanto Company | Enhanced starch biosynthesis in tomatoes |
US5789156A (en) | 1993-06-14 | 1998-08-04 | Basf Ag | Tetracycline-regulated transcriptional inhibitors |
US5814618A (en) | 1993-06-14 | 1998-09-29 | Basf Aktiengesellschaft | Methods for regulating gene expression |
WO1998055595A1 (en) | 1997-06-03 | 1998-12-10 | Rutgers, The State University Of New Jersey | Plastid promoters for transgene expression in the plastids of higher plants |
US5877402A (en) | 1990-05-01 | 1999-03-02 | Rutgers, The State University Of New Jersey | DNA constructs and methods for stably transforming plastids of multicellular plants and expressing recombinant proteins therein |
WO1999046394A1 (en) | 1998-03-11 | 1999-09-16 | Novartis Ag | Novel plant plastid promoter sequence |
WO2000007431A1 (en) | 1998-08-03 | 2000-02-17 | Rutgers, The State University Of New Jersey | Translation control elements for high-level protein expression in the plastids of higher plants and methods of use thereof |
WO2000020611A1 (en) | 1998-10-01 | 2000-04-13 | Eidgenössische Technische Hochschule Zürich | Improved transformation of plastids |
WO2001007590A2 (en) | 1999-07-27 | 2001-02-01 | Syngenta Participations Ag | Chimeric genes for plastid expression |
EP1076095A1 (en) | 1999-08-09 | 2001-02-14 | Riken | Methods for transformation of plants, transformed plants and processes for preparation of polyesters |
WO2001042441A2 (en) | 1999-12-08 | 2001-06-14 | International Centre For Genetic Engineering And Biotechnology | Plastid transformation |
US20060253916A1 (en) | 2001-12-20 | 2006-11-09 | Christian Biesgen | Methods for the transformation of vegetal plastids |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2561330A (en) * | 1948-03-25 | 1951-07-24 | Phillips Petroleum Co | Process for refining soybean oil |
WO2001029059A1 (en) * | 1999-10-15 | 2001-04-26 | The Ohio State University Research Foundation | Methods for analyzing the insertion capabilities of modified group ii introns |
US7534936B2 (en) * | 2001-03-29 | 2009-05-19 | Rutgers, The State University Of New Jersey | Transgenic plants having transformed plastid genomes and progeny thereof |
US20040142476A1 (en) * | 2002-11-01 | 2004-07-22 | New England Biolabs, Inc. | Organellar targeting of RNA and its use in the interruption of environmental gene flow |
US8062891B2 (en) * | 2003-10-24 | 2011-11-22 | Gencia Corporation | Nonviral vectors for delivering polynucleotides to plants |
FR2878532B1 (en) * | 2004-11-26 | 2007-03-02 | Genoplante Valor Soc Par Actio | METHOD OF ADDRESSING NUCLEIC ACIDS TO PLASTS |
GB2449466B (en) * | 2007-05-23 | 2009-11-18 | Algentech Ltd | Production of proteins in plant tissue |
-
2008
- 2008-11-25 GB GB0821516.2A patent/GB2465749B/en active Active
-
2009
- 2009-11-25 CA CA2781900A patent/CA2781900C/en active Active
- 2009-11-25 WO PCT/GB2009/002754 patent/WO2010061186A2/en active Application Filing
- 2009-11-25 ES ES09795795.5T patent/ES2614499T3/en active Active
- 2009-11-25 US US13/131,004 patent/US9567598B2/en active Active
- 2009-11-25 AU AU2009321351A patent/AU2009321351B2/en not_active Ceased
- 2009-11-25 EP EP09795795.5A patent/EP2367942B1/en active Active
-
2017
- 2017-01-17 US US15/407,685 patent/US20170121724A1/en not_active Abandoned
Patent Citations (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4684611A (en) | 1982-02-11 | 1987-08-04 | Rijksuniversiteit Leiden | Process for the in-vitro transformation of plant protoplasts with plasmid DNA |
EP0116718A1 (en) | 1983-01-13 | 1984-08-29 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Process for the introduction of expressible genes into plant cell genomes and agrobacterium strains carrying hybrid Ti plasmid vectors useful for this process |
EP0175966A1 (en) | 1984-09-25 | 1986-04-02 | Calgene, Inc. | Plant cell microinjection technique |
US5100792A (en) | 1984-11-13 | 1992-03-31 | Cornell Research Foundation, Inc. | Method for transporting substances into living cells and tissues |
US5569597A (en) | 1985-05-13 | 1996-10-29 | Ciba Geigy Corp. | Methods of inserting viral DNA into plant material |
WO1987006614A1 (en) | 1986-04-30 | 1987-11-05 | Boyce Thompson Institute For Plant Research, Inc. | Electric field mediated dna transformation of plant cells and organelles |
US5268463A (en) | 1986-11-11 | 1993-12-07 | Jefferson Richard A | Plant promoter α-glucuronidase gene construct |
US5608142A (en) | 1986-12-03 | 1997-03-04 | Agracetus, Inc. | Insecticidal cotton plants |
EP0270355A2 (en) | 1986-12-03 | 1988-06-08 | Agracetus, Inc. | Genetic engineering of cotton plants and lines |
EP0290395A2 (en) | 1987-05-05 | 1988-11-09 | Sandoz Ag | Plant tissue transformation |
EP0331083A2 (en) | 1988-03-02 | 1989-09-06 | Schweizerische Eidgenossenschaft Eidgenössische Technische Hochschule (Eth) | Method for the production of transgenic plants |
WO1990012096A1 (en) | 1989-04-03 | 1990-10-18 | Purdue Research Foundation | Method for enhancing transmembrane transport of exogenous molecules |
EP0434616A1 (en) | 1989-12-19 | 1991-06-26 | Ciba-Geigy Ag | Method and appliance for the genetic transformation of cells |
DE4005152A1 (en) | 1990-02-17 | 1991-08-22 | Guenter Prof Dr Kahl | Transforming plant protoplast(s) with DNA-histone complex - providing high and reproducible transfer rate, and expression of foreign genes |
EP0444882A2 (en) | 1990-02-26 | 1991-09-04 | Agracetus, Inc. | Plant transformation process with early identificaton of germ line transformation events |
US5466785A (en) | 1990-04-12 | 1995-11-14 | Ciba-Geigy Corporation | Tissue-preferential promoters |
US5877402A (en) | 1990-05-01 | 1999-03-02 | Rutgers, The State University Of New Jersey | DNA constructs and methods for stably transforming plastids of multicellular plants and expressing recombinant proteins therein |
US5608149A (en) | 1990-06-18 | 1997-03-04 | Monsanto Company | Enhanced starch biosynthesis in tomatoes |
EP0486234A2 (en) | 1990-11-14 | 1992-05-20 | Pioneer Hi-Bred International, Inc. | Plant transformation method using agrobacterium species |
EP0486233A2 (en) | 1990-11-14 | 1992-05-20 | Pioneer Hi-Bred International, Inc. | Plant transformation method using agrobacterium species |
WO1992009696A1 (en) | 1990-11-23 | 1992-06-11 | Plant Genetic Systems, N.V. | Process for transforming monocotyledonous plants |
WO1992014828A1 (en) | 1991-02-14 | 1992-09-03 | Svalöf Ab | Method for genetic transformation of tissue organs from monocotyledonous plants |
US5399680A (en) | 1991-05-22 | 1995-03-21 | The Salk Institute For Biological Studies | Rice chitinase promoter |
US5604121A (en) | 1991-08-27 | 1997-02-18 | Agricultural Genetics Company Limited | Proteins with insecticidal properties against homopteran insects and their use in plant protection |
WO1994000583A1 (en) | 1992-06-23 | 1994-01-06 | South Dakota State University | Transformation of plants by direct injection of dna |
US5789156A (en) | 1993-06-14 | 1998-08-04 | Basf Ag | Tetracycline-regulated transcriptional inhibitors |
US5814618A (en) | 1993-06-14 | 1998-09-29 | Basf Aktiengesellschaft | Methods for regulating gene expression |
US5608144A (en) | 1994-08-12 | 1997-03-04 | Dna Plant Technology Corp. | Plant group 2 promoters and uses thereof |
WO1997006250A1 (en) | 1995-08-10 | 1997-02-20 | Rutgers University | Nuclear-encoded transcription system in plastids of higher plants |
WO1998055595A1 (en) | 1997-06-03 | 1998-12-10 | Rutgers, The State University Of New Jersey | Plastid promoters for transgene expression in the plastids of higher plants |
WO1999046394A1 (en) | 1998-03-11 | 1999-09-16 | Novartis Ag | Novel plant plastid promoter sequence |
WO2000007431A1 (en) | 1998-08-03 | 2000-02-17 | Rutgers, The State University Of New Jersey | Translation control elements for high-level protein expression in the plastids of higher plants and methods of use thereof |
WO2000020611A1 (en) | 1998-10-01 | 2000-04-13 | Eidgenössische Technische Hochschule Zürich | Improved transformation of plastids |
WO2001007590A2 (en) | 1999-07-27 | 2001-02-01 | Syngenta Participations Ag | Chimeric genes for plastid expression |
EP1076095A1 (en) | 1999-08-09 | 2001-02-14 | Riken | Methods for transformation of plants, transformed plants and processes for preparation of polyesters |
WO2001042441A2 (en) | 1999-12-08 | 2001-06-14 | International Centre For Genetic Engineering And Biotechnology | Plastid transformation |
US20060253916A1 (en) | 2001-12-20 | 2006-11-09 | Christian Biesgen | Methods for the transformation of vegetal plastids |
Non-Patent Citations (81)
Title |
---|
"Physical methods for the transformation of plant cells are reviewed in Oard", BIOTECH. ADV., vol. 9, 1991, pages 1 - 11 |
A. DEPICKER ET AL., J. OF MOL. & APPLIED GEN., vol. 1, 1982, pages 561 - 573 |
ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403 - 10 |
AUSUBEL ET AL.: "Current Protocols in Molecular Biology, Second Edition,", 1992, JOHN WILEY & SONS |
BEVAN, NUCL. ACIDS RES., vol. 12, 1984, pages 8711 - 8721 |
BOEKE ET AL., MOL. CELLUL. BIOLOGY, vol. 8, 1988, pages 1432 - 1442 |
CADDICK ET AL., NATURE BIOTECHNOLOGY, vol. 16, 1998, pages 177 - 180 |
CANEVASCINI ET AL., PLANT PHYSIOL., vol. 112, no. 2, 1996, pages 513 - 524 |
CAO ET AL., PLANT CELL REP., vol. 11, 1992, pages 585 - 591 |
CHRISTENSEN ET AL., PLANT MOL. BIOL., vol. 12, 1989, pages 619 - 632 |
CHRISTENSEN ET AL., PLANT MOL. BIOL., vol. 18, 1992, pages 675 - 689 |
CHRISTOU ET AL., BIO/TECHNOLOGY, vol. 9, 1991, pages 957 - 962 |
CLOUGH; BENT, PLANT JOURNAL, vol. 16, 1998, pages 735 - 743 |
COUSINEAU ET AL., CELL, vol. 94, 1998, pages 451 - 462 |
DATTA ET AL., BIO/TECHNOLOGY, vol. 8, 1990, pages 736 - 740 |
D'HALLUIN ET AL., PLANT CELL, vol. 4, 1992, pages 1495 - 1505 |
FREEMAN ET AL., PLANT CELL PHYSIOL., vol. 29, 1984, pages 1353 |
FRIANT ET AL., MOL. CELLUL. BIOLOGY, vol. 18, 1998, pages 799 - 806 |
FROMM ET AL., BIO/TECHNOLOGY, vol. 8, 1990, pages 833 - 839 |
GATZ ET AL., MOL. GEN. GENET., vol. 227, 1991, pages 229 - 237 |
GOFFEAU ET AL., SCIENCE, vol. 274, no. 5287, 1996, pages 546 - 547 |
GORDON-KAMM ET AL., PLANT CELL, vol. 2, 1990, pages 603 - 618 |
GREEN ET AL.: "Plant Tissue and Cell Culture", 1987, ACADEMIC PRESS |
GUERINEAU; MULLINEAUX: "Plant Molecular Biology", 1993, BIOS SCIENTIFIC PUBLISHERS, article "Plant transformation and expression vectors", pages: 121 - 148 |
GUEVARA-GARCIA ET AL., PLANT J., vol. 4, no. 3, 1993, pages 495 - 505 |
HAJDUKIEWICZ P T J ET AL., EMBO J, vol. 16, 1997, pages 4041 - 4048 |
HANSEN ET AL., MOL. GEN GENET., vol. 254, no. 3, 1997, pages 337 - 343 |
HELLENS ET AL., PLANT MOL. BIOL, vol. 42, 2000, pages 819 - 832 |
HERDENBERGER F ET AL., NUCL ACIDS RES, vol. 22, 1994, pages 2869 - 2875 |
HIEI ET AL., THE PLANT JOURNAL, vol. 6, 1994, pages 271 - 282 |
HOLLANDER V; KUCK U, NUCL ACIDS RES, vol. 27, 1999, pages 2339 - 2344 |
HORSCH ET AL., SCIENCE, vol. 227, 1985, pages 1229 - 1231 |
JENKINS B.D. ET AL., THE PLANT CELL, vol. 9, March 1997 (1997-03-01), pages 283 - 296 |
KAWAMATA ET AL., PLANT CELL PHYSIOL., vol. 38, no. 7, 1997, pages 792 - 803 |
KINDLE, PNAS U.S.A., vol. 87, 1990, pages 1228 |
KONCZ; SCHELL, MOL GEN GENET, vol. 204, 1986, pages 383 - 396 |
KOZIEL ET AL., BIOTECHNOLOGY, vol. 11, 1993, pages 194 - 200 |
KRUGER K ET AL., CELL, vol. 31, 1982, pages 147 - 157 |
KUCK U ET AL., NUCL ACIDS RES, vol. 18, 1990, pages 2691 - 2697 |
LAM, RESULTS PROBL. CELL DIFFER., vol. 20, 1994, pages 181 - 196 |
LAST ET AL., THEOR. APPL. GENET., vol. 81, 1991, pages 581 - 588 |
LI ET AL., PLANT CELL REP., vol. 12, 1993, pages 250 - 255 |
LIERE K; MALIGA P, EMBO J, vol. 18, 1999, pages 249 - 257 |
MARSHALL; KEEGSTRA, PHYSIOLOGY, vol. 100, 1992, pages 1048 - 1054 |
MATSUOKA ET AL., PROC NATL. ACAD. SCI. USA, vol. 90, no. 20, 1993, pages 9586 - 9590 |
MCELROY ET AL., PLANT CELL, vol. 2, 1990, pages 163 - 171 |
MCNELLIS ET AL., PLANT J., vol. 14, no. 2, 1998, pages 247 - 257 |
MORAN ET AL., MOL CELL BIOL, vol. 15, 1995, pages 2828 - 2838 |
NAR, vol. 12, no. 22, 1984, pages 8711 - 87215 |
ODELL ET AL., NATURE, vol. 313, 1985, pages 810 - 812 |
OROSZ A. ET AL., EUR. J. BIOCHEMISTRY, vol. 201, no. 3, 2005, pages 653 - 659 |
OROZCO ET AL., PLANT MOL BIOL., vol. 23, no. 6, 1993, pages 1129 - 1138 |
PEARSON; LIPMAN, PNAS USA, vol. 85, 1988, pages 2444 - 2448 |
PENG ET AL., INTERNATIONAL RICE RESEARCH INSTITUTE, MANILA, PHILIPPINES, 1991, pages 563 - 574 |
RATHORE ET AL., PLANT MOLECULAR BIOLOGY, vol. 21, 1993, pages 871 - 884 |
RINEHART ET AL., PLANT PHYSIOL., vol. 112, no. 3, 1996, pages 1331 - 1341 |
ROMAN J; WOODSON S A, PROC NATL ACAD SCI USA, vol. 95, 1998, pages 2134 - 2139 |
RUSSELL ET AL., TRANSGENIC RES., vol. 6, no. 2, 1997, pages 157 - 168 |
SAMBROOK ET AL.: "Molecular Cloning: a Laboratory Manual, Second Edition,", 1989, COLD SPRING HARBOR LABORATORY PRESS |
SCHENA ET AL., PROC. NATL. ACAD. SCI. USA, vol. 88, 1991, pages 10421 - 10425 |
SHIMAMOTO ET AL., NATURE, vol. 338, 1989, pages 274 - 276 |
SHIMAMOTO, K., CURRENT OPINION IN BIOTECHNOLOGY, vol. 5, 1994, pages 158 - 162 |
SMITH; WATERMAN, ADV. APPL. MATH., vol. 2, 1981, pages 482 - 489 |
SOMERS ET AL., BIO/TECHNOLOGY, vol. 10, 1992, pages 1589 - 1594 |
TORIYAMA ET AL., BIO/TECHNOLOGY, vol. 6, 1988, pages 1072 - 1074 |
VAIN ET AL., BIOTECHNOLOGY ADVANCES, vol. 13, no. 4, 1995, pages 653 - 671 |
VAN CAMP ET AL., PLANT PHYSIOL., vol. 112, no. 2, 1996, pages 525 - 535 |
VASIL ET AL., BIO/TECHNOLOGY, vol. 10, 1992, pages 667 - 674 |
VASIL ET AL.: "Laboratory Procedures and Their Applications", 1984, ACADEMIC PRESS, article "Cell Culture and Somatic Cell Genetics of Plants" |
VASIL, I. K., PLANT MOLECULAR BIOLOGY, vol. 25, 1994, pages 925 - 937 |
VASIL, NATURE BIOTECHNOLOGY, vol. 14, 1996, pages 702 |
VELTEN ET AL., EMBO J., vol. 3, 1984, pages 2723 - 2730 |
VERNHETTES, MOL. BIOL. EVOL., vol. 15, no. 7, 1998, pages 827 - 836 |
WALTERS ET AL., PLANT MOLECULAR BIOLOGY, vol. 18, 1992, pages 189 - 200 |
WAN; LEMAUX, PLANT PHYSIOL., vol. 104, 1994, pages 37 - 48 |
WEEKS ET AL., PLANT PHYSIOLOGY, vol. 102, 1993, pages 1077 - 1084 |
WEISS BACH; WEISS BACH: "Methods for Plant Molecular Biology", 1989, ACADEMIC PRESS |
YAMAMOTO ET AL., PLANT CELL PHYSIOL., vol. 35, no. 5, 1994, pages 773 - 778 |
YAMAMOTO ET AL., PLANT J., vol. 12, no. 2, 1997, pages 255 - 265 |
ZHANG ET AL., PLANT CELL REP., vol. 7, 1988, pages 379 - 384 |
ZHANG ET AL., THEOR. APPL. GENET, vol. 76, 1988, pages 835 - 840 |
Cited By (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011034945A1 (en) | 2009-09-15 | 2011-03-24 | Metabolix, Inc. | Generation of high polyhydroxybutrate producing oilseeds |
WO2011034946A1 (en) | 2009-09-15 | 2011-03-24 | Metabolix, Inc. | Generation of high polyhydroxybutrate producing oilseeds |
WO2012037324A2 (en) | 2010-09-15 | 2012-03-22 | Metabolix, Inc. | Increasing carbon flow for polyhydroxybutyrate production in biomass crops |
WO2013064119A1 (en) | 2011-11-03 | 2013-05-10 | The University Of Hong Kong | Methods using acyl-coenzyme a-binding proteins to enhance drought tolerance in genetically modified plants |
US10273496B2 (en) | 2014-12-17 | 2019-04-30 | Basf Se | Plants with improved photosynthetic carbon fixation capacity |
CN104585020A (en) * | 2015-01-15 | 2015-05-06 | 福建农林大学 | Breeding method of purple-leaf erect panicle type giant embryo glutinous rice variety |
CN104585020B (en) * | 2015-01-15 | 2016-08-17 | 福建农林大学 | A kind of selection of purple leaf erect head giant embryo glutinous rice kind |
WO2016164810A1 (en) | 2015-04-08 | 2016-10-13 | Metabolix, Inc. | Plants with enhanced yield and methods of construction |
EP3502253A1 (en) | 2015-06-18 | 2019-06-26 | The Broad Institute Inc. | Novel crispr enzymes and systems |
US11773412B2 (en) | 2015-06-18 | 2023-10-03 | The Broad Institute, Inc. | Crispr enzymes and systems |
WO2016205764A1 (en) | 2015-06-18 | 2016-12-22 | The Broad Institute Inc. | Novel crispr enzymes and systems |
US11180751B2 (en) | 2015-06-18 | 2021-11-23 | The Broad Institute, Inc. | CRISPR enzymes and systems |
US11060115B2 (en) | 2015-06-18 | 2021-07-13 | The Broad Institute, Inc. | CRISPR enzymes and systems |
US11421250B2 (en) | 2015-06-18 | 2022-08-23 | The Broad Institute, Inc. | CRISPR enzymes and systems |
WO2016205711A1 (en) | 2015-06-18 | 2016-12-22 | The Broad Institute Inc. | Novel crispr enzymes and systems |
WO2016205749A1 (en) | 2015-06-18 | 2016-12-22 | The Broad Institute Inc. | Novel crispr enzymes and systems |
EP3009511A2 (en) | 2015-06-18 | 2016-04-20 | The Broad Institute, Inc. | Novel crispr enzymes and systems |
EP4159856A1 (en) | 2015-06-18 | 2023-04-05 | The Broad Institute, Inc. | Novel crispr enzymes and systems |
EP3666895A1 (en) | 2015-06-18 | 2020-06-17 | The Broad Institute, Inc. | Novel crispr enzymes and systems |
WO2017070605A1 (en) | 2015-10-22 | 2017-04-27 | The Broad Institute Inc. | Type vi-b crispr enzymes and systems |
WO2017184786A1 (en) | 2016-04-19 | 2017-10-26 | The Broad Institute Inc. | Cpf1 complexes with reduced indel activity |
WO2017219027A1 (en) | 2016-06-17 | 2017-12-21 | The Broad Institute Inc. | Type vi crispr orthologs and systems |
US11788083B2 (en) | 2016-06-17 | 2023-10-17 | The Broad Institute, Inc. | Type VI CRISPR orthologs and systems |
WO2018045321A1 (en) * | 2016-09-02 | 2018-03-08 | North Carolina State University | Methods and compositions for modification of plastid genomes |
US11739308B2 (en) | 2017-03-15 | 2023-08-29 | The Broad Institute, Inc. | Cas13b orthologues CRISPR enzymes and systems |
EP4361261A2 (en) | 2017-03-15 | 2024-05-01 | The Broad Institute Inc. | Novel cas13b orthologues crispr enzymes and systems |
WO2018191388A1 (en) | 2017-04-12 | 2018-10-18 | The Broad Institute, Inc. | Novel type vi crispr orthologs and systems |
US11591601B2 (en) | 2017-05-05 | 2023-02-28 | The Broad Institute, Inc. | Methods for identification and modification of lncRNA associated with target genotypes and phenotypes |
WO2019060746A1 (en) | 2017-09-21 | 2019-03-28 | The Broad Institute, Inc. | Systems, methods, and compositions for targeted nucleic acid editing |
US10968257B2 (en) | 2018-04-03 | 2021-04-06 | The Broad Institute, Inc. | Target recognition motifs and uses thereof |
US11999767B2 (en) | 2018-04-03 | 2024-06-04 | The Broad Institute, Inc. | Target recognition motifs and uses thereof |
WO2020033601A1 (en) | 2018-08-07 | 2020-02-13 | The Broad Institute, Inc. | Novel cas12b enzymes and systems |
WO2020131862A1 (en) | 2018-12-17 | 2020-06-25 | The Broad Institute, Inc. | Crispr-associated transposase systems and methods of use thereof |
WO2020191102A1 (en) | 2019-03-18 | 2020-09-24 | The Broad Institute, Inc. | Type vii crispr proteins and systems |
WO2020206046A1 (en) | 2019-04-01 | 2020-10-08 | The Broad Institute, Inc. | Methods and compositions for cell therapy |
WO2020236967A1 (en) | 2019-05-20 | 2020-11-26 | The Broad Institute, Inc. | Random crispr-cas deletion mutant |
WO2021041922A1 (en) | 2019-08-30 | 2021-03-04 | The Broad Institute, Inc. | Crispr-associated mu transposase systems |
WO2024113408A1 (en) * | 2022-11-28 | 2024-06-06 | 深圳大学 | Construction method for episome plasmids in chlamydomonas reinhardtii chloroplasts and use thereof |
Also Published As
Publication number | Publication date |
---|---|
GB2465749B (en) | 2013-05-08 |
ES2614499T3 (en) | 2017-05-31 |
CA2781900A1 (en) | 2010-06-03 |
US20110321187A1 (en) | 2011-12-29 |
CA2781900C (en) | 2023-02-14 |
WO2010061186A3 (en) | 2010-07-22 |
US20170121724A1 (en) | 2017-05-04 |
GB0821516D0 (en) | 2008-12-31 |
US9567598B2 (en) | 2017-02-14 |
EP2367942B1 (en) | 2016-10-19 |
AU2009321351A2 (en) | 2011-06-16 |
EP2367942A2 (en) | 2011-09-28 |
GB2465749A (en) | 2010-06-02 |
AU2009321351B2 (en) | 2016-05-26 |
AU2009321351A1 (en) | 2010-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2009321351B2 (en) | Method for the transformation of plant cell plastids | |
US20220267784A1 (en) | Protein production in plant cells | |
EP2367941B1 (en) | Method for the transformation of plant cell mitochondria | |
US20200024611A1 (en) | Gene targeting in plants using a chimeric multi domain recombination protein | |
US9982270B2 (en) | Organic compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09795795 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009321351 Country of ref document: AU Ref document number: 3584/CHENP/2011 Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 2009321351 Country of ref document: AU Date of ref document: 20091125 Kind code of ref document: A |
|
REEP | Request for entry into the european phase |
Ref document number: 2009795795 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009795795 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13131004 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2781900 Country of ref document: CA |